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SUMMARY 
Aldosterone is a mineralocorticoid hormone with pleiotropic actions in the body. 
Among others, aldosterone controls sodium and potassium excretion in kidney and 
colon and it was proposed to play an important role during pregnancy. Most of the 
previous studies examining the in vivo role of aldosterone have been performed in 
adrenalectomized animals. However, the often incomplete removal of adrenal tissue 
and the existence of local aldosterone producing systems in various organs 
complicated deciphering the precise role of aldosterone. In this thesis, we took 
advantage of the recently developed aldosterone-synthase-deficient (AS-/-) mice to 
analyse the role of aldosterone in the control of potassium homeostasis and 
pregnancy. AS-/- mice lack any endogenous aldosterone production, have slightly 
elevated plasma corticosterone levels, a reduced bodyweight despite increased food 
intake, but are otherwise clinically normal.    
AS-/- and AS+/+ mice were kept for two days either on a standard diet (0.8% 
K+), or diets enriched with potassium (2% K+, 3% K+ and 5% K+). The AS-/- mice 
adapted well to 2% K+ diet. Urinary K+ excretion rose similar in AS-/- and AS+/+ mice 
and plasma K+ levels remained in the normal range. With 3% K+ diet,   AS-/- mice 
tended to become hyperkalemic and on 5% K+ diet, the AS-/- mice were fully 
decompensated and exhibited severe hyperkalemia and K+-food avoidance. 
Therefore, all following studies were performed on mice kept either on standard or 
on 2% K+ diets. First, we analyzed the effect of dietary K+ loading on the abundance 
and subcellular localization of the renal outer medullary potassium channel (ROMK) 
and the epithelial sodium channel (ENaC) in the kidney. ROMK and ENaC are 
expressed in the aldosterone-sensitive distal nephron (ASDN) comprising the late 
distal convoluted tubule (DCT2), the connecting tubule (CNT), and the collecting duct 
(CD). ROMK is thought to mediate most of renal K+ excretion, while Na+-
reabsorption via ENaC provides the electrochemical driving force for K+ secretion 
across the apical plasma membrane. Accordingly, we found that dietary K+ loading 
(2% K+) causes a translocation of ROMK and ENaC from intracellular compartments 
to the apical plasma membrane of the ASDN. The apical translocation of ENaC was 
accompanied by a proteolytic cleavage of the α- and γ-subunits of ENaC, which is 
thought to activate ENaC. Apical translocation of ROMK and ENaC, as well the 
proteolytic activation of ENaC was similar in AS+/+ and AS-/- mice. Consistently, patch 
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clamp experiments on isolated split-open tubules revealed similar whole cell 
amiloride-sensitive Na+ channel currents in the early ASDN of AS+/+ and AS-/- mice. 
Likewise, on the 2% K+ diet, AS+/+ and AS-/- mice showed the same natriuretic 
response to a single amiloride injection. To address the possible mechanism for the 
aldosterone-independent activation of ENaC in the early ASDN, we treated AS+/+ and 
AS-/- mice on 2% K+ diet with the angiotensin II AT1 receptor antagonist losartan. 
While AS+/+ mice tolerated losartan treatment without any problems, AS-/- mice 
decompensated and developed severe hypokalemia with K+-food avoidance. 
Immunohistochemistry revealed that losartan-treatment of AS-/- mice impaired the 
apical translocation of ENaC. Interestingly, AS-/- mice showed reduced abundance 
and phosphorylation of the thiazide-sensitive NaCl-cotransporter (NCC), which was 
present already on standard diet and became even more pronounced on high K+-
diet. Consistent with lowered NCC activity, AS-/- mice on 2% K+ diet showed lesser 
natriuresis than AS+/+ mice in response to hydrochlorothiazide. Ussing-type chamber 
experiments on isolated colon mucosa from AS+/+ and AS-/- mice showed that dietary 
K+ intake (2% K+ for 2-4 days) increases Ba+-sensitive K+ channel and amiloride-
sensitive Na+ channel currents only in AS+/+ but not in AS-/- mice. Taken together our 
results suggest that aldosterone-deficiency does not prevent the K+-intake-induced 
functional adaptation of ROMK and ENaC in the kidney, but impairs the homeostatic 
response of BK and ENaC in the colon. Angiotensin-II dependent activation of ENaC 
and functional downregulation of NCC in the renal tubule likely contribute to the 
maintenance of K+ homeostasis in the absence of aldosterone. NCC downregulation 
in DCT enhances Na+ delivery to the ASDN, which can be reabsorbed via 
angiotensin II activated ENaC and hence increases the driving force for K+-secretion 
via ROMK.  
During normal pregnancy, plasma volume expands to increase the perfusion 
of the placenta and support fetal growth. The extension of plasma volume coincides 
with a gradual increase in plasma aldosterone levels. Clinical studies revealed 
aldosterone deficiency in a subgroup of women in pregnancy-associated disorders 
like pre-eclampsia. Therefore, we aimed to test in our mouse model the hypotheses 
whether chronic aldosterone deficiency may contribute or cause pre-eclampsia or 
intra-uterine growth restriction (IUGR). In order to avoid differing genotypes of pups 
as a confounding factor, we used only two types of breeding (AS+/+ male mating with 
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AS-/- female and AS-/- male mating with AS+/+ female) giving heterozygous pups only. 
Hypertension and proteinuria are considered as cardinal signs of pre-eclampsia. 
Therefore, we measured systolic blood pressure (SBP) and proteinuria in AS+/+ and 
AS-/- females to check for the development of pre-eclampsia. AS-/- mice did not 
develop hypertension or proteinuria but showed significantly decreased litter sizes. 
To investigate the possible mechanism for decreased litter sizes, pregnant mice 
were sacrificed on day 18 of pregnancy. At this stage, AS-/- females already showed 
a reduced number of fetuses that correlated with an increased number of necrotic 
placentas. Also, the weights of the fetuses and the placentas were lower in AS-/- than 
in AS+/+ females. Histology of healthy placentas from AS+/+ and AS-/- mice showed 
similar structures including a normal decidua basalis, junctional zone, and labyrinth, 
while necrotic placentas showed severe coagulative necrosis and infiltration of 
lymphocytes in all three layers. Consistently, necrotic placentas revealed increased 
mRNA levels of the pro-inflammatory cytokine tumor necrosis factor 1alpha (TNF1), 
and the monocyte chemo-attractant protein 1 (MCP-1). We hypothesized that 
aldosterone deficiency decreases plasma volume and arterial perfusion, which finally 
compromise placental and foetal growth due to placental hypoxia. Consistent with 
placental hypoxia, we found a significantly increased protein expression of hypoxia 
inducible factor 1 (HIF1α) in placentas of AS-/- mice when compared with AS+/+ mice.  
In order to improve plasma volume during pregnancy, we fed a high salt diet 
(5% NaCl) to females. AS+/+ and AS-/- female mice responded well to high salt diet as 
indicated by an increased SBP during high salt diet. During pregnancy, SBP 
decreased in both genotypes. Litter size was slightly improved but necrotic placentas 
were still observed in AS-/- mice. However, increased weight of pups was observed in 
AS+/+ and AS-/- females on high salt diet during pregnancy compared to control diet. 
In mice of both genotypes, placental efficiency was significantly improved by the high 
salt diet suggesting a better perfusion of the placenta, which may have improved 
growth of the fetuses. Accoridingly, HIF1α expression levels were similar in 
placentas from AS+/+ and AS-/- females on high salt diet. 
In summary, using AS-/- mice, we revealed aldosterone-dependent and 
independent mechanisms for K+ homeostasis in the kidney and the colon. The 
aldosterone-independent mechanisms allow for maintenance of K+-homeostasis in 
the absence of any aldosterone by activation of ROMK and ENaC in the kidney and 
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perhaps down-regulation of NCC. In contrast to the kidney, the colonic adaptation to 
dietary K+ intake appears to strictly depend on aldosterone.  We also demonstrated, 
using AS-/- mice, that aldosterone deficiency affects placental function during 
pregnancy leading to reduced placental and fetal growth. Dietary salt 
supplementation during pregnancy can partially improve placental function. 
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DEUTSCHE  ZUSAMMENFASSUNG DER DOKTORARBEIT 
Aldosteron ist ein Mineralokortikoidhormon, das hauptsächlich in der Nebenniere 
gebildet wird und unterschiedlichste Körperfunktionen beeinflussen kann. Unter 
anderem spielt Aldosteron eine zentrale Rolle bei der Regulierung der Natrium- und 
Kaliumausscheidung durch Nieren und Dickdarm. Auch während der 
Schwangerschaft scheint Aldosteron eine wichtige Funktion zu haben. 
Bisherige in vivo Untersuchungen zur physiologischen Bedeutung von 
Aldosteron wurden vor allem an adrenalektomierten Tieren durchgeführt. Die oft 
unvollständige Entfernung der Nebennieren und eine gewisse extraadrenale 
Produktion von Aldosteron erschwert  aber eine eindeutige Interpretation der 
gewonnenen Daten. In dieser Doktorarbeit nutzten wir Aldosteronsynthase-defiziente 
(AS-/-) Mäuse, die keine endogene Aldosteronproduktion mehr haben, um die Rolle 
von Aldosteron bei der Aufrechterhaltung der Kaliumhomöostase und während der 
Schwangerschaft genauer zu untersuchen. AS-/-Mäuse weisen leicht erhöhte 
Plasma-Kortikosteron Werte auf, haben ein stark aktiviertes Renin-Angiotensin-
System und ein reduziertes Körpergewicht, sind aber ansonsten weitgehend 
unauffällig. 
Wir untersuchten die Fähigkeit von AS-/- Mäusen sich an unterschiedliche 
Kaliumaufnahmen anzupassen. Dazu fütterten wir AS-/- Mäuse und Wild-typ (AS+/+) 
Mäuse für zwei Tage entweder mit einer Standard Diät mit einem Kaliumgehalt von 
0.8% K+ oder einer K+-angereicherten  Diät mit 2% K+,  3%K+ oder 5%K+. Wir 
stellten fest, dass sich die AS-/- Mäuse gut an die 2% K+-Diät anpassen können. Wie 
die AS+/+ Mäuse erhöhten sie die K+ Ausscheidung im Urin und hielten so ihre 
Plasma K+-Konzentration auf einem normalen Wert. Ab einer K+-Anreicherung von 
3% zeigten die AS-/- aber erste Anzeichen einer Hyperkalämie. Wurde der 
Kaliumgehalt der Diät noch weiter auf 5% gesteigert dekompensierten die AS-/- 
Mäuse vollständig. Sie zeigten eine ausgeprägte Hyperkalämie und verweigerten die 
weitere Aufnahme der 5% K+-Diät. Aufgrund dieser Beobachtungen wurden alle 
weiteren Untersuchungen nur noch an Mäusen, die mit der Standard Diät oder der 
2% K+-Diät gefüttert wurden, durchgeführt. 
Zuerst untersuchten wir den Einfluss einer erhöhten Kalium Aufnahme auf die 
Menge und die subzelluläre Lokalisierung des  K+-Kanals ROMK und des 
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epithelialen Na+-Kanals ENaC, die im Aldosteron-abhängigen distalen Teil des 
Nephrons, dem sogenannten ASDN, vorkommen. Im ASDN vermittelt ROMK die K+-
Ausscheidung über die apikale Plasmamembran. Die notwendige elektrochemische 
Triebkraft für die K+-Sekretion wird durch eine ENaC-vermittelten Na+-Aufnahme 
aufgebaut. Hierzu passend fanden wir nach einer erhöhten Kaliumaufnahme (2%K+) 
eine Verlagerung von  ROMK und ENaC aus intrazellulären Kompartimenten an die 
apikale Plasmamembran entlang des ASDN. Die Verlagerung von ENaC ging mit 
einer proteolytischen Spaltung und Aktivierung der alpha- und der gamma- 
Untereinheit von ENaC einher. Die apikale Translokation von ROMK und ENaC und 
die proteolytische Aktivierung von ENaC beobachten wir gleichermassen in AS+/+ 
und in AS-/- Mäusen. Parallel zeigten Patch-Clamp Untersuchungen an isolierten 
Tubuli von AS+/+ und AS-/- Mäusen ähnliche Na+-Ströme, die mit Amilorid blockierbar 
waren. Beide Genotypen zeigten auch die gleiche natriuretische Antwort auf eine 
Amilorid-Injektion.  
Um den möglichen Mechanismus der Aldosteron-unabhängigen Aktivierung 
von ENaC aufzuklären, behandelten wir  die AS+/+ und AS-/- Mäuse mit Losartan, 
einem Hemmer des Angiotensin II (AT1) Rezeptors. Während die AS+/+ Mäuse diese 
Behandlung problemlos tolerierten, dekompensierten die AS-/- Mäuse. Sie 
entwickelten eine deutliche Hyperkalämie und verweigerten die K+-Diät Aufnahme. 
Immunhistochemische Untersuchungen zeigten, dass bei den AS-/- Mäuse nach der 
Losartan-Behandlung die apikale Translokation von ENaC nicht mehr nachweisbar 
war.  
Interessanterweise zeigten die die AS-/- Mäuse bereits unter Standard-
Bedingungen eine geringere Menge und Phosphorylierung des renalen Natrium-
Chlorid-Cotransporters (NCC) als die AS+/+ Mäuse. Die Abnahme von NCC Menge 
und Phosphorylierung in den AS-/- Mäuse wurde noch deutlicher, wenn die K+-
Konzentration der Diät erhöht wurde. In Übereinstimmung mit diesen 
Beobachtungen zeigten AS-/- Mäuse auf der 2% K+-Diät eine geringere natriuretische 
Antwort auf eine Thiazid-Injektion als die entsprechenden AS+/+ Mäuse. 
Ussing-Kammer-Untersuchungen am Colon zeigten, dass eine erhöhte K+-
Aufnahme (2% K+) für 2-4 Tage sowohl Ba+-hemmbare K+-Kanäle als auch Amilorid-
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hemmbare Na+-Kanäle aktiviert. Diese Aktivierung der K+ und Na+ Kanäle war aber 
nur in den AS+/+  und nicht in AS-/- Mäusen nachweisbar. 
Zusammengefasst deuten unsere Resultate darauf hin, dass das Fehlen von 
Aldosteron die funktionelle Anpassunge der Niere an eine erhöhte K+-Aufnahme 
nicht verhindert. Im Gegensatz dazu scheint die homeostatische Anpassung des 
Colons an eine erhöhte K+-Aufnahme an Aldosteron gebunden zu sein. In der Niere 
scheint eine Angiotensin II-abhängige Aktivierung von ENaC und eine 
Herunteregulierung von NCC an der Aldosteron-unabhängigen Erhaltung K+-
Homöostase beteiligt zu sein. Die Herunterregulierung von NCC im DCT führt zu 
einer erhöhten Beladung des ASDNs mit Na+, welches dann via ENaC resorbiert 
wird und damit die elektrochemische Triebkraft für die ROMK-abhängige K+-
Sekretion erhöht. 
 Während einer normalen Schwangerschaft vergrössert sich das mütterliche 
Plasmavolumen um die Durchblutung der Plazenta  zu optimieren und damit das 
Wachstum des Fötus zu begünstigen. Die Ausdehnung des Plasmavolumens geht 
mit einer Erhöhung  der Plasma-Aldosteron-Spiegel einher. In klinischen Studien 
wurde bei einzelnen werdenden Müttern mit Präeklampsie ein Aldosteron Mangel 
nachgewiesen. Daher testeten wir in unserem Maus-Modell die Hypothese, dass ein 
chronischer  Aldosteron-Mangel die Schwangerschaft negativ beeinflusst und eine 
Präeklampsie und/oder einen intrauterinen Wachstumsverzug (IUGR) zur Folge 
haben kann.  
Damit ausschliesslich heterozygote Jungtiere gezeugt wurden, wurden nur 
männliche AS+/+  mit weiblichen AS-/- und männlich AS-/-  mit weiblichen AS+/+ 
verpaart. Bei den schwangeren Weibchen wurden dann während des gesamten 
Schwangerschaftsverlaufes der systolische Blutdruck (SBP) und die 
Proteinausscheidung im Urin gemessen, um zu kontrollieren, ob die Tiere die 
charakterischen Zeichen einer Präeklampsie (Bluthochdruck und Proteinurie) 
entwickelten. Wir konnten keine Anzeichen eines Bluthochdruckes oder einer 
Proteinurie bei den Mäusen entdecken. Die AS-/- Mütter hatten aber deutlich kleinere 
Würfe als die AS+/+ Mütter. Das gehäufte Vorkommen nekrotischer Plazenten 
deutete an, dass die reduzierte Wurfgrösse auf ein intrauterines Absterben der 
Frucht zurückzuführen war. Nicht nur die Anzahl der Föten war bei AS-/- Müttern 
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geringer als bei AS+/+ Müttern, sondern auch das Gewicht der entwickelten Föten 
und der dazugehörigen gesunden Plazenten war deutlich reduziert. Obwohl kleiner, 
zeigten die gesunden Plazenten der Mütter beider Genotypen einen strukturell 
unauffälligen histologischen Befund. Im Gegensatz dazu zeigten die nekrotischen 
Plazenten eine lymphozytäre Infiltration und eine erhöhte Transkription für das 
inflamatorische Zytokin Tumor-Necrosis-Factor 1 alpha (TNF1α) und das Monocyte 
Chemo-Attractant Protein1 (MCP-1). Wir nehmen an, dass der Aldosteronmangel 
das Plasmavolumen der schwangeren Mäuse verringert. Damit ist die optimale 
arterielle Blutversorgung der Plazenten nicht mehr gewährleistet, was zu einer 
plazentaren Hypoxie und damit zu einem beeinträchtigten plazentaren und damit 
fötalen Wachstum führt. Die Vermutung einer plazentaren Hypoxie in den AS-/- 
Mütter wird durch die Beobachtung einer signifikant erhöhten Expression des 
Hypoxie-Induzieren-Faktor 1 alpha (HIF1α) unterstützt. 
Um das vermeintlich zu geringe Plasmavolumen der AS-/- Mäuse während der 
Schwangerschaft zu optimieren, fütterten wir die werdenden Mütter mit einer NaCl-
angereicherten Diät (5% NaCl). Sowohl die AS+/+ als auch die AS-/- Weibchen 
reagierten gut auf die Diät und zeigten vor und während der Schwangerschaft 
erhöhte Blutdruckwerte. Durch die NaCl-angereicherte Diät konnte die Wurfgrösse 
der AS-/- Mäuse deutlich erhöht werden. Auch das Gewicht der Jungtiere war sowohl 
bei den AS+/+ Tieren als auch bei den AS-/- unter der NaCl-reichen-Diät deutlich 
erhöht. Trotzdem wurden bei den AS-/- Mäusen weiterhin nekrotische Plazenten 
gefunden. Um den möglichen Mechanismus der verbesserten Gewichtsentwicklung 
der Jungtiere zu verstehen berechneten wir die plazentäre Effizienz welche durch 
das Verhältnis von Plazentagrösse zu Jungtiergrösse bestimmt wird. Beide 
Genotypen zeigten eine deutliche erhöht Effizienz der Plazenta was darauf 
hindeutet, dass dem erhöhten Geburtsgewicht der Jungtiere eine verbesserte 
Durchblutung der Plazenta zugrunde liegt. 
Zusammenfassend, konnten wir durch unsere Untersuchungen and den AS-/- 
Mäusen Aldosteron-abhängige und -unabhängige Mechanismen zur Erhaltung der 
K+-Homöostase aufklären. Die Aldosteron-unabhängigen Mechanismen ermöglichen 
es durch eine Aktivierung von ROMK und ENaC und eine Herunterregulatierung von 
NCC in der Niere die K+-Homöostase auch bei fehlendem Aldosteron aufrecht zu 
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erhalten. Im Gegensatz dazu scheint die Anpassung des Colons an eine erhöhte K+-
Aufnahme an Aldosteron gebunden zu sein. 
Die Untersuchungen der AS-/- Mäuse zeigten auch, dass ein 
Aldosteronmangel in der Schwangerschaft die Funktion der Plazenta negativ 
beeinflusst und in der Folge zu einer Reduktion des plazentalen und fötalen 
Gewichts führt. Eine Supplementierung der Diät mit NaCl scheint die Effizienz der 
Plazenta zumindest teilweise zu verbessern. 
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1 INTRODUCTION  
Aldosterone 
Aldosterone is the main mineralocorticoid hormone produced in the glomerulosa cell 
layer of the adrenal glands. Aldosterone has pleiotropic actions in the body as shown 
in figure 1. One of its main functions is to participate to the hormonal control of ion 
and water homeostasis. Aldosterone stimulates sodium (Na+) reabsorption and 
potassium (K+) secretion by the kidney. As Na+ is the primary active osmotic particle 
in the extracellular space and retains water, aldosterone finally determines the 
volume of extracellular fluid and hence blood pressure [1]. Aldosterone has also 
effects on many other organ systems including the cardiovascular system and 
metabolic organs. Moreover, local synthesis of aldosterone has been demonstrated 
in tissues such as those of the heart, blood vessels and brain [2-4]. The functions of 
aldosterone in these non-epithelial tissues are still a matter of debate. Recently 
aldosterone has been shown to play a role during pregnancy, in which it may 
contribute to plasma volume expansion, placental perfusion and hence improved 
placental and fetal growth [5, 6]. In our projects, we focussed on the role of 
aldosterone in K+ homeostasis and in pregnancy. As aldosterone is produced by the 
enzyme aldosterone synthase (AS), AS knock out (AS-/-) mice were used to study 
the role of aldosterone 
 
 
Figure  1. Pleiotropic role of aldosterone (adapted and modified from [7]) 
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Aldosterone synthase (Cyp11b2) 
Aldosterone is synthesized from cholesterol by a series of enzymatic reactions of 
which aldosterone synthase (AS, Cyp11b2) mediate the last two reactions using 11-
deoxycorticosterone as a substrate (figure 2). Aldosterone synthase produces 
aldosterone by catalyzing first the hydroxylation of 11-deoxycorticosterone to 
corticosterone, then the 18-hydroxylation of corticosterone to 18-
hydroxycorticosterone, and finally the oxidation of 18-hydroxycorticosterone to 
aldosterone [8] (figure 2). Aldosterone-deficient mice were generated by  the Oliver 
Smithies group by targeted disruption of Cyp11b2 gene and kindly provided to us. In 
these aldosterone-synthase knockout (AS-/-) mice, the first two exons of the gene 
were replaced via homologous recombination with a nucleotide sequence coding for 
the expression of the enhanced green fluorescent protein (EGFP). AS-/- mice lack 
any endogenous aldosterone, have a reduced body weight (75% of the wild type 
mice), are hypotensive and show very high levels of plasma renin and angiotensin II, 
and slightly elevated levels of plasma corticosterone  [9].  
 
 
Figure 2. Flow chart showing function of aldosterone synthase enzyme in aldosterone 
production 
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1.1 Project 1. Role of aldosterone in renal potassium excretion 
1.1.1 Aldosterone synthesis and regulation  
The major role of aldosterone is to stimulate sodium (Na+) reabsorption and 
potassium (K+) secretion in target tissues. The zona glomerulosa cells from the 
adrenal cortex contain the aldosterone synthase enzyme involved in the final step of 
aldosterone production from deoxycorticosterone. The gene encoding for the 
aldosterone synthase is Cyp11b2.  
There are three main factors that control aldosterone production, namely angiotensin 
II, plasma K+ levels, and adrenocorticotropic hormone (ACTH). Angiotensin II is 
formed during extracellular volume depletion via an activation of the renin-
angiotensin-system. In response to a decrease in the circulating blood volume renin 
is released from the granular cells in the renal juxtraglomerular apparatus. Renin 
converts angiotensinogen (produced mostly by the liver) into angiotensin I by 
proteolytic cleavage.Angiotensin I in turn is then converted by the angiotensin 
converting enzyme (ACE) into the physiologically active angiotensin II. Angiotensin II 
binds then to the AT1 receptor on the glomerulosa cells of the adrenal cortex to 
stimulate aldosterone production. An increase in extracellular K+ concentrations 
directly stimulates aldosterone production in the glomerulosa cells by not yet well 
understood mechanism. ACTH is released from the anterior pituitary mainly to 
stimulate glucocorticoid productions. However, it  does also promote aldosterone 
secretion although this effect is very weak [1]. 
1.1.2 Target tissues and specificity for the receptors 
Aldosterone mediates its effect by binding to the type 1 corticosteroid or the 
mineralocorticoid receptor (MR). The MR is a ligand activated transcription factor 
and is a member of the steroid/thyroid hormone nuclear receptor superfamily of 
ligand inducible transcription factors [10]. The MR receptor is expressed in the 
epithelium lining the tubules in the distal nephron of the kidney, the distal colon, and 
the ducts of salivary and sweats glands. Glucocorticoids exert their effects through 
the glucocorticoid receptors (GR) [11]. Steroid binding studies showed that both, 
aldosterone and glucocorticoid, have similar high affinities for the MR [10]. Plasma 
levels of glucocorticoids hormones are 100 to 1000 times higher than that of 
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aldosterone (0.1 to 1nM) and theoretically expected to occupy MR. However, in 
aldosterone target tissues the MR is protected by the enzyme 11β-hydroxysteroid 
dehydrogenase type 2 (11β-HSD2) which converts cortisol and corticosterone, but 
not aldosterone, to their in-active 11-keto analog. These analog are unable to 
activate the MR [12]. Thus, in aldosterone target tissues specificity for the MR is 
mediated by the 11β-HSD2 enzyme. 
 Since the eighties of the last century, several additional target tissues for 
aldosterone have been defined. Expression of MR was reported in a number of non-
epithelial tissues including the pituitary, neurons of the central nervous system 
(CNS), cardiac myocytes, and endothelial and smooth muscle cells of the large 
vessels [10-13]. Cardiac myocytes [14], vascular cells [15] and certain areas of the 
adult brain, related to control of blood pressure and salt appetite, appear to express 
11β-HSD2 [16] suggesting that aldosterone may exert specific effects at this sites, 
despite the high circulating glucocorticoid levels. Nevertheless, the physiological role 
of the MR or aldosterone in these non-epithelial tissues has remained largely 
unknown whereas patho-physiological effects of aldosterone at these sites are the 
subject of intense studies [17]. Aldosterone was shown to contribute to cardiac 
fibrosis and cardiovascular remodelling in animals on high salt diet [18]. There is also 
evidence that aldosterone contributes to inflammation, fibrosis and progression of 
cardiovascular diseases, including hypertension and metabolic syndrome [19]. 
Interestingly, expression of the 11β-HSD2 and the MR in human placenta was also 
reported indicating a role of aldosterone in pregnancy [20]. The possible role of 
aldosterone in pregnancy will be discussed in more detail in a later part of the 
introduction.   
1.1.3 Potassium homeostasis - External and internal K+ balance  
Control of K+ homeostasis is vital for the function of many cells in the body. A high 
intracellular concentration of K+ is important for cell growth whereas the maintenance 
of extracellular K+ concentrations is important for normal functions of neurons, 
cardiac myocytes and skeletal muscle [1, 21]. Hypokalemia or hyperkalemia result in 
cardiac arrhythmias and dysfunction of neurons and muscle contraction (weakness 
and cramps). The amount of K+ in the extracellular space is rather low. The K+ 
content of a standard meal could be already sufficient to increase extracellular K+ 
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concentration. Thus, dietary K+ intake has to be managed by rapid redistribution of 
taken-up, extracellular K+ into intracellular tissue stores, particularly in muscle and 
liver cells. Eventually K+ is released back into the extracellular fluid and gets 
excreted by the kidney into the urine [21]. Safeguarding of plasma K+ is achieved by 
synchronised mechanisms of external and internal K+ balance. External K+ balance 
involves the rate of K+ intake (approx.100 mEq/day) and the rate of K+ excretion 
through urine (approx. 90 mEq/day) and faeces (approx. 10 mEq/day). The internal 
K+ balance consists of distribution of K+ between extracellular fluid (approx. 70 
mEq/day) and intracellular spaces in bone, liver, muscle and red blood cells (figure 
3). This distribution is regulated by several hormones like insulin, β-adrenergic 
agonists (e.g. epinephrine) and aldosterone all promoting the transport of K+ from 
extracellular fluid to intracellular fluid compartments via the ubiquitous Na+-K+- 
ATPase pump. This process of distribution can be further affected by acid-base 
balance and the tonicity of the plasma  [1, 22].   
   
Figure 3.  Potassium homeostasis. External and internal K+ balances (adapted and 
modified from [22]). Detail description in text. 
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External K+ balance is mainly determined by two organs, namely the kidney 
and the colon. The kidneys play a major role in K+ homeostasis by excreting 90 to 
95% of the daily K+ intake while the colon excretes 5 to 10% of the daily K+ intake. 
Although the colon can increase K+ excretion under certain conditions like in 
response to adrenal hormones, decreased renal excretory capacity and high K+ diet, 
the colon alone cannot excrete K+ to the extent to maintain normal plasma K+ levels 
[1]. K+ secretion is under tight control of aldosterone, which acts as the final 
endocrine signal of the renin–angiotensin-aldosterone system and targets the 
epithelia in the kidney and colon [17]. 
1.1.4 Potassium handling in the kidney 
In the kidney, potassium is freely filtered in the glomerulus, almost completely 
reabsorbed in the proximal tubule (almost 80%) and thick ascending limb (TAL) 
(10%), secreted in the connecting tubule (CNT) and cortical collecting duct (CCD) 
and reabsorbed in the outer medullary collecting duct (OMCD).   
Potassium absorption 
Figure 4 depicts the different cell models for K+ absorption along the nephron. 
 
Figure 4. Potassium absorption along the nephron. Cell models showing similarities of 
transporters in the basolateral membrane and different transporters at the apical membrane, 
(adapted and modified from [23]) 
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In the proximal tubule, K+ is reabsorbed by two paracellular mechanisms: 
solvent drag and passive diffusion. Active Na+ transport in the proximal tubule drives 
net fluid absorption and drags K+ along with the fluid. The transcellular ion transport 
also generates at the end of the proximal tubule a lumen-positive transepithelial 
voltage that provides an electrochemical gradient for K+ absorption through the low 
resistance paracellular pathway.  In the TAL, K+ is mostly recycledthrough the Na+-
K+-2Cl- -cotransporter (NKCC2) and the ROMK channel [1, 23, 24].  
1.1.5 Potassium secretion - Critical role of the ASDN 
The amount of K+ that finally becomes excreted in the urine critically depends on 
controlled K+ secretion along the aldosterone-sensitive distal nephron (ASDN). The 
ASDN comprises the late distal convoluted tubule (DCT2), the connecting tubule 
(CNT), and the collecting duct (CD) [22, 24]. In the ASDN, two morphologically 
distinct cell types are present namely principal cells (PC) and intercalated cells (IC) 
[22, 25] (figure 5). The PCs are involved in K+ secretion, whereas ICs are involved in 
K+ absorption [26, 27]. Principal cells express epithelial Na+ channels (ENaC) and 
renal outer medullary K channels (ROMK) localized to the apical membrane and the 
Na+-K+-ATPase on the basolateral membrane [28]. Transepithelial sodium 
absorption via ENaC and Na+-K+-ATPase is electrogenic and generates a lumen-
negative transepithelial potential difference that acts as a driving force for K+ 
secretion via apical K+ channels such as ROMK and the flow dependent maxi K+ 
channels (BK) [24, 29-31]. Potassium secretion in the PC is a two step process that 
involves first an active uptake of K+ across the basolateral membrane by Na+-K+- 
ATPases and then second the passive diffusion of K+ through apical K+ channels 
along the  electrochemical gradient generated by ENaC and the Na+-K+ ATPase 
(figure 4) [22]. Aldosterone stimulates K+ secretion by activation of the Na+-K+- 
ATPase, ENaC, and perhaps also the apical K+ channels. Aldosterone sensitivity is 
conferred to the ASDN by the expression of the MR and the 11β-HSD2 in the ASDN 
[28, 32]. Potassium absorption by intercalated cells occurs by an active transport of 
K+ via H+-K+-ATPases across the apical membrane and leaving the cell across the 
basolateral membrane along a favourable K+ electrochemical gradient (figure 5) [24, 
33, 34].  
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Figure 5. Potassium secretion and absorption in the Aldosterone-sensitive distal 
nephron. Principal cell show expression of the Epithelial Sodium channel (ENaC), the Renal 
outer medullary potassium channel (ROMK), Na+-K+-ATPase, and the mineralcorticoid 
receptor (MR). Intercalated cell shows expression of H+-K+-ATPase, vacuolar H+-ATPase 
and Na+-K+- ATPase.  
In addition to aldosterone, a variety of other factors including dietary K+ intake, 
vasopressin (antidiuretic hormone – ADH) and tubular flow rate [22, 23, 27, 35] have 
been shown to stimulate either K+ secretion of absorption along the ASDN (figure 6). 
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Figure  6. Regulatory factors influencing K+ secretion or absorption in the ASDN 
(adapted from [23].) 
 
 
Figure 7. Expression and distribution patterns of Na+ and K+ transport systems along 
the ASDN. Distribution of the MR and 11β-HSD2 and the DCT specific thiazide sensitive 
NCC are also indicated. (Adapted and modified from [28]). 
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1.1.6 Structure, function and regulation of sodium and potassium 
channels and transporter in the ASDN 
1.1.6.1 The epithelial sodium channel (ENaC) 
ENaC plays an important role in whole body Na+, K+ and fluid homeostasis. 
 
Figure 8. Structure of the ENaC channel (as predicted by Jasti et al [36]). Adapted from 
[37] 
This is emphasised by the observations that gain of function mutations of 
ENaC such as in Liddle’s syndrome lead to severe arterial hypertension and 
hypokalemia whereas loss of function mutations of ENaC such as in 
pseudohypoaldosteronism type 1 (PHA-I) lead to a renal salt wasting syndrome and 
hypotension associated with hyperkalemia [38, 39]. ENaC is a heteromultimeric 
channel consisting of three different homologous subunits α, β and γ (figure 8). The 
three subunits share 30 to 40% homology at the level of amino acid sequence [28, 
40]. ENaC might be a heterotrimer as suggested by the crystal structure of related 
acid sensing ion channel 1 (ASIC1) [36, 41]. Each subunit of ENaC consists of two 
transmembrane domains (M1 and M2), a large extracellular loop and short intra-
cellular amino and carboxy termini. It is thought that ENaC forms its pore with their 
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M2 domains [38]. Co-expression of all three ENaC subunits is necessary for full 
activity of the channel. Na+ movement across the channel corresponds to the 
electrophysiologically measurable ion currents and can be specifically blocked by the 
diuretics amiloride and triamterene [38, 42]. 
ENaC is regulated by a variety of extrinsic and intrinsic factors. Figure 9 and 
table 1 shows some of these factors.  
Extrinsic factors  
Hormonal regulation - ENaC is known to be regulated by volume regulatory 
hormones such as aldosterone, arginine vasopressin (AVP), the atrial natriuretic 
peptide (ANP), and other hormones such as insulin and endothelin [37]. The 
hormones regulate ENaC via receptor mediated modulation of intracellular signalling 
pathways including kinase cascades. Aldosterone regulates ENaC - by stimulation of 
the serum and glucocorticoid-regulated kinase (Sgk1) or inhibition of the extracellular 
signal-regulated kinase (ERK) [43, 44]. AVP and ANP, insulin and endothelin 
regulate ENaC via protein kinase A (PKA), phosphatidylinositol 3-kinase-dependent 
signalling and SRC family kinases, respectively [45-49].  
Table 1. Factors regulating ENaC  
Extrinsic factors Intrinsic factors 
Hormonal regulation ENaC traffiking 
Mechanosensation Phosphorylation 
Proteolytic cleavage Na
+ self inhibition and feedback inhibition 
 Metabolic depletion and pH 
 
Mechanosensation - In non-epithelial tissues, ENaCs subunits were shown to be 
involved in mechanosensation. The β and γ subunits may play an important role in 
the mechanosensitivity of neurons innervating the aortic arch and vascular smooth 
muscles [50, 51]. Also in isolated rabbit CCD, ENaC might become activated by 
laminar shear stress due to an increased tubular flow rate [52]. ENaC activation via 
shear forces occurs likely directly via an increased opening probability (Po) of the 
channel [37, 53-55]. 
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Figure 9. Summary of extrinsic and intrinsic factors regulating ENaC channel (adapted 
from [37]). 
Proteolytic cleavage - Recent evidence indicates activation of ENaCs by proteolytic 
processing by intra and extracellular proteases. One such ENaC activation protease 
is furin. Furin is a serine protease, which is highly abundant in the trans-golgi 
network and likely cleaves ENaC already during the biosynthetic pathway. Furin 
likely cleaves the α- and the γ-ENaC subunits at two and one extracellular sites, 
respectively [56]. The furin-dependent cleavage of the α-ENaC subunit releases an 
inhibitory peptide from the extracellular loop of ENaC and thereby activates the 
channel [57, 58]. Another ENaC-activation protease is prostasin, which is also called 
"channel activating peptidase 1 (CAP-1)". Prostasin is an extracellular protease that 
likely cleaves γ-ENaC in the extracellular loop in close proximity to the furin cleavage 
site. The combined actions of prostasin and furin release then an inhibitory peptide 
from γ-ENaC to fully activate ENaC [59]. 
Intrinsic factors  
ENaC trafficking - ENaC activity is also regulated by trafficking to and from the 
plasma membrane. The three different ENaC subunits are synthesized in the 
endoplasmic reticulum (ER) and modified along the biosynthetic pathway before they 
traffic from intracellular pools to the apical plasma membrane [60]. ENaC is 
endocytosed into clathrin-coated vesicles and may be recycled back to the apical 
plasma membrane or is shuttled to lysosomes or proteasomes for degradation [61, 
62]. Several cellular and molecular mechanisms are involved in ENaC trafficking. 
One of the best studied regulatory proteins is the ubiquitin-protein ligase Nedd4-2. 
26 
 
Nedd4-2 interacts with a proline-rich PPXY (PY) motif of ENaC subunits, promotes 
ubiquitylation, which is followed by endocytosis and proteasomal degradation of the 
channel [63]. Another ENaC trafficking associated protein is AS160, a Rab protein 
regulator, which stabilises ENaC in an intracellular compartment preventing the 
channel from trafficking to the apical membrane [64]. 
Phosphorylation - Regulation of ENaC by kinases via direct phosphorylation of its 
subunits or phosphorylation of proteins interacting and regulating the channel is well 
known [28, 42]. One of the best studied kinases is the aldosterone induced kinase 
Sgk1 which stimulates cell surface activity and density of ENaC via direct 
phosphorylation of the α-subunit [65] and indirectly via phosphorylation of Nedd4-2 
and AS160 [64, 66]. Phosphorylated Nedd4-2 or AS160 are recognised and blocked 
by 14-3-3 proteins, which prevents Nedd4-2-dependent endocytosis and AS160-
mediated intracellular retention that eventually increases the channel density and 
activity at the apical plasma membrane [28, 64].  
1.1.6.2 ROMK 
The channel (Kir1.1) is a member of the inwardly rectifying K+ channel family [67] 
with high K+ selectivity [68].  
 
Figure  10. A schematic structural model of ROMK. A. Proposed subunit structure. B. 
Two of the 4 subunits illustrate the pore helices in the M1 and M2 linker (taken from [30]. 
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ROMK is a pore forming protein expressed in the apical membrane of the TAL 
and PC of the ASDN [30]. X-ray crystallography of homologous K+ channels from 
Streptomyces lividans [69], suggest that the ROMK channel is a tetrameric channel 
complex. Each monomer consists of two membrane spanning segments (M1 and 
M2) and cytoplasmic N- and C-termini with high homology to the pore-forming H5 
segment of voltage-gated K+ channels [24]. Studies on the packing structure of the 
M1 and M2 domains by Minor et al. suggest that the M2 segments line the pore and 
are surrounded by M1 segments which also participate in subunit-subunit 
interactions [70] (figure 10).ROMK channels are sensitive to intracellular pH. 
Channel activity is completely inhibited by a decrease in the cytosolic pH from 7.4 to 
7.0 [71, 72]. An important property of ROMK channels is the sensitivity to 
intracellular ATP concentrations. High concentrations of ATP inhibit channel activity 
(milimolar range) whereas low concentrations of ATP (submilimolar range) are found 
to activate the channel [22, 73]. ROMK channels are also known to be regulated by 
phosphorylation. The ROMK channel has three putative PKA phosphorylation sites 
and stimulation of these sites increases channel activity [74, 75] either by insertion of 
ROMK channels into the plasma membrane [76, 77] or by augmenting the effect of 
phosphatidylinositol phosphates (PIP2) [78], which activates ROMK channels [79]. 
Moreover, Sgk1 stimulates ROMK channel activity by phosphorylation of a serine 
residue at the N-terminus of ROMK [80]. Protein kinase C (PKC) has both 
stimulatory as well as inhibitory effects on ROMK channels as phosphorylation 
induces export of channels to the cell membrane but decreases the sensitivity of 
channels to PIP2 [81, 82]. The ROMK1 channel variant is also regulated by PTK 
which increases endocytosis of channels in the CCD by tyrosine phosphorylation 
[24].  
1.1.6.3 BK or Maxi K channels 
A large conductance Ca+ activated K+ channel (also called BK or Maxi K) is reported 
to be expressed in various nephron segments such as the medullary and cortical 
TAL, DCT, CNT, CCD and medullary collecting duct. The functional BK channel 
consist of a pore forming α subunit (Slo 1) with six transmembrane segments and 
one of the four accessory β subunits (β1, β2, β3, and β4). The β1 subunit is reported 
to be expressed exclusively in the CNT mostly in the PCs in mouse whereas other 
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subunits β2-β4 are thought to be expressed in the CCD. BK β2 and β3 are found to 
be expressed in either IC or PC of the CCD and β4 is expressed in IC of the CNT 
and CCD [24, 83]. It has been shown that BK channels are also sensitive to cellular 
pH and ATP at physiological Ca2+ levels [84, 85]. BK channels may have a role in 
flow induced K+ secretion along CNT and the CCD [86, 87]. This function of BK 
channels was further emphasised by the failure of increasing flow induced K+ 
secretion in BK-α subunit knockout mice. Interestingly, net K+ excretion in response 
to high K+ diet was normal in the knockout mice indicating that K+-diet induced 
ROMK channels may compensate for non-functional BK channels [88]. Similarly, BK 
channels appear to contribute to urinary K+ excretion in ROMK-deficient mice, 
suggesting that ROMK and BK channels are somehow redundant in function and 
can partially compensate for each other [89]. 
1.1.6.4 NCC 
As shown in figure 7, the ASDN begins within the distal convoluted tubule (DCT). In 
the DCT, sodium transport depends on the thiazide-sensitive sodium-chloride co-
transporter (NCC), which is co-expressed with ENaC in the late DCT (DCT2).   
 
Figure 11. Phosphorylation and activation of NCC (adapted and modified from [91] ) 
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NCC, encoded by the Slc12a3 gene, is a member of the cation-chloride 
cotransporter family which also includes the Na+-K+-2Cl- cortransporters NKCC2 and 
NKCC1 [90]. In the distal tubule NCC plays a critical role in NaCl  reabsorption and, 
indirectly in, K+ homeostasis [91].A recent study has shown a decrease in the 
amount of total and surface NCC due to dietary K+ intake indicating a role of NCC in 
K+ homeostasis [92] NCC and two other members of the family, NKCC2 and 
NKCC1, are known to be activated by phosphorylation at their amino termini in 
response to low chloride concentrations. Recently it has been shown that 
mammalian sterile 20 (STE20)-like kinases STE20/SPS1-related proline/alanine-rich 
kinase (SPAK) and oxidative stress-responsive kinase 1 (OSR1) phosphorylate NCC 
at three specific residues: Thr46, Thr55 and Thr60 in human NCC. The regulation of 
NCC by complex interactions of different kinases is shown in figure 11. The SPAK 
and OSR1 enzymes are further phosphorylated and activated by another set of 
kinases, With-No-Lysine Kinase 1 and 4 (WNK1 and WNK4). Recently, it has been 
shown that WNK3 also stimulates NCC activity by inhibiting WNK4. 
All WNK kinases 1, 2 and 3 are expressed in the DCT. A shorter transcript of 
WNK1 lacking its kinase domain is expressed only in the kidney (Ks-WNK1) 
stimulates NCC activity by blocking the inhibitory effect of WNK-1L on WNK4. 
Aldosterone has been shown to activate NCC through Sgk1 dependent 
phosphorylation of WNK4 kinase thus possibly blocking the inhibitory effect of WNK4 
on NCC [91, 93]. 
The critical role of NCC for Na+ and K+ homeostasis is evidenced by genetic 
diseases that over-activate or block NCC function. In Familial Hyperkalemic 
Hypertension, also known as Gordon’s syndrome or Pseudohypoaldosteronism type 
II (PHAII), mutations in WNK kinases causes an abnormal high activity of NCC 
leading to hypertension, hyperkalemia and metabolic acidosis [94]. In contrast, loss-
of-function mutations within NCC cause Gitelman-syndrome characterized by renal 
Na+ wasting, hypokalemia and metabolic alkalosis [95]. Interestingly, some of the 
patients with Gitelman-syndrome have mutations at position 60 confirming the critical 
relevance of the serine residue at this site for the activation of NCC via 
phosphorylation [96].      
30 
 
1.1.7 Potassium handling by the colon 
The colon does also participate in the control of K+ homeostasis. Although under 
standard conditions, only 10% of the ingested K+ is excreted via the colon, colonic K+ 
excretion may dramatically rise and become crucial in chronic renal insufficiency 
[97]. On the other hand, intestinal K+ loss during diarrhoea can lead to extreme forms 
of acute hypokalemia [98]. The colon can participate in active K+ absorption and 
secretion [99, 100]. Under normal conditions, the proximal colon secretes K+ while 
the distal colon contributes to net K+ absorption via the non-gastric H+/K+-ATPase 
(HKα2) present in the apical membrane of the surface cells [97]. On a high K diet, 
both proximal and distal colon secretes K+ via trans- and paracellular pathways [101, 
102]. 
 
Figure 12. Colonocyte: showing different channels and transporters in the apical and 
basolateral membranes.  
 The transcellular pathway involves active transport of K+ into the cell via the 
basolateral Na+/K+ pump and the co-transporter NKCC1. K+ is then secreted through 
apical K+ channels [103, 104] that is in the colon the BK channel [97, 105].  In 
addition, to transcellular K+ secretion, paracellular K+ fluxes have been described 
[103]. Both the transcellular and the paracellular pathway for net K+ secretion 
depend on the lumen negative transepithelial voltage [106, 107], which is like in the 
kidney generated by transepithelial sodium reabsorption via ENaC (figure 12) [97]. 
Moreover, like the ASDN, the distal colon is aldosterone-sensitive and aldosterone 
plays an important role in the regulation of K+ transport in the colon as well [108].    
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1.2 Project 2. Role of aldosterone in pregnancy 
1.2.1 Pregnancy specific disorder- Pre-eclampsia  
Pregnancy is characterized by a profound volume expansion due to high aldosterone 
levels meant to support fetal well-being [6]. Pre-eclampsia is a clinical syndrome in 
pregnant women defined as the new onset of hypertension and proteinuria after 20 
weeks of gestation. It affects 3-5% of all pregnancies and is the leading cause of 
maternal and fetal morbidity and mortality. The criteria to define hypertension are a 
systolic blood pressure level ≥140 mmHg or a diastolic level ≥90 mmHg on two or 
more occasions at least 4 to 6 hr apart. Proteinuria is defined as the urinary 
excretion of more than 0.3 g protein in 24 hr urine samples, or a protein 
concentration of more than 0.3 g/l protein or ≥1+ on dipstick test strips when two 
random urine samples are taken 4-6 hr apart. The etiology of pre-eclampsia is 
unknown but is likely to be multifactorial [109]. Risk factors include a previous history 
of pre-eclampsia, multiple pregnancies, nulliparity, high body mass index before 
pregnancy, maternal age older than 40 years, very young maternal age, diabetes 
mellitus, renal disease, chronic hypertension, metabolic syndrome, hypercoagulable 
states, and more than 10 years since the last pregnancy [109, 110]. 
1.2.2 Pregnancy specific disorder- IUGR  
Another pregnancy specific disorder is intrauterine growth restriction or retardation 
(IUGR). IUGR is the impairment of fetal growth due to anatomical and/or functional 
disorders and diseases of the feto-placental-maternal unit [111]. IUGR is usually 
defined as less than 10% of the predicted fetal weight for gestational age and, if not 
diagnosed properly, may result in significant fetal morbidity and mortality [67]. IUGR 
is further subdivided into symmetrical and asymmetrical IUGR. Symmetrical IUGR 
consists of low weight, length and head circumference and is usually indicative of 
processes originating early in pregnancy. In contrast asymmetrical IUGR consists of 
sparing of fetal head circumference and length (relatively large head with 
undergrown trunk and extremities) indicative of processes occurring in the later 
stages of gestation. Symmetrical IUGR is caused by several diseases including 
genetic disorders (trisomies, other chromosomal disorders and constitutional), dwarf 
syndromes, congenital viral infections, some inborn errors of metabolism and 
intrauterine drug exposures. Asymmetrical IUGR is mostly due to impaired utero-
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placental function or nutrient deficiency. There are many different risk factors for 
IUGR, among them placental insufficiency and pre-eclampsia are included [112]. 
1.2.3 Abnormal placental implantation - common to pre-eclampsia and 
IUGR 
During normal pregnancy, maternal uetroplacental blood flow increases drastically to 
support the growth of the fetus (figure 13). The uteroplacental arteries, also called 
spiral arteries, undergo a series of pregnancy specific changes that include 1) 
endovascular invasion of trophoblast and apparent replacement of endothelium and 
media smooth muscle cells, 2) loss of elasticity of the arteries, 3) dilation of arteries 
to wide and in-contractile tubes, 4) and finally loss of vasomotor control.  
 
Figure 13. Modulation of spiral arteries. Comparison in non-pregnant, normal pregnancy 
and pregnancy associated with IUGR or preeclampsia (adapted from [113]). 
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The remodelling of the spiral artery increases uteroplacental perfusion and 
reduces maternal vascular blood flow resistance to meet the requirement of the 
fetus. Moreover, vasodilation and loss of vasomotor control guarantee sufficient 
blood supply to the placenta irrespective of altered regulation of vascular resistance 
and blood pressure in the mother [114]. 
IUGR and pre-eclampsia have in common an abnormal vascular remodelling 
and placental implantation. Brosens and colleagues [115] demonstrated decreased 
trophoblast invasion and absence of pregnancy specific changes in spiral arteries in 
pregnancies with IUGR and preeclampsia and it is now well accepted that reduced 
endovascular trophoblast invasion and spiral artery remodelling are key pathogenic 
features of IUGR and pre-eclampsia as shown in figure 9. Basic research and clinical 
data indicate that the inadequate invasion of uteroplacental arteries results from the 
concerted action of intrinsic fetal factors (abnormal biology of extravillous 
trophoblasts) and extrinsic maternal uterine factors including impaired decidual 
remodeling, impaired function of uterine natural killer (NK) cells and expression of 
endothelial adhesion molecules [110, 113]. Hypoxia is considered to be a central 
feature of both IUGR and pre-eclampsia [116-118]. Hypoxia driven dysregulation of 
placental angiogenesis via hypoxia inducible factor (HIF) may be a key to the altered 
trophoblast maturation associated with IUGR or pre-eclampsia. Pro-inflammatory 
cytokines can influence HIF which in turn can alter the expression of cytokines and 
therefore modify trophoblast invasion [118-123]. Low oxygen tension has been 
demonstrated to inhibit the normally invasive phenotype of cytotrophoblasts needed 
for deep placental implantation [124]. Several animal models showing pre-eclampsia 
like syndromes have been constructed by disruption of uterine, placental, or renal 
blood flow and indicated that prepregnancy endothelial dysfunction underlies hypoxia 
induced shallow placentation [125, 126]. 
1.2.4 IUGR and pre-eclampsia may have different pathophysiologies 
Although endothelial dysfunction appears to be a common predisposing factor for 
both IUGR and pre-eclampsia, the clinical outcome and the consequences for the 
mother might be completely different. Therefore some authors suggest that IUGR 
and pre-eclampsia may represent pathophysiologically separate entities [127]. 
However, other authors suggest that depending on the presence of other co-
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morbidities such as obesity, metabolic syndrome, coagulopathies, and maternal 
inflammation, predisposed pregnant women may either develop IUGR only or the 
full-blown phenotype of pre-eclampsia (figure 14) [118].  
 
Figure 14. Proposed pathogenesis of IUGR and Pre-eclampsia (adapted from [118].  
In fact, tobacco smoking causes marked endothelial dysfunction and cytokine 
elevation [128], but it is strongly associated with IUGR only and surprisingly inversely 
correlated with pre-eclampsia [129, 130]. Tobacco smokers tend to be lean and so 
probably are protected from metabolic syndrome and thus from development of pre-
eclampsia whereas the relatively rare group of smokers with concomitant metabolic 
syndrome may have elevated risk for developing fulminant pre-eclampsia [118]. 
1.2.5 Placental efficiency- an important factor for fetal growth 
Size and growth of the fetus at birth are important for determining the morbidity and 
mortality immediately after birth and during later life. Children small or large for 
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gestational age or with IUGR are more prone for developing adult-onset 
degenerative diseases, such as type 2 diabetes and glucose intolerance [131]. An 
important factor or process for fetal growth is placental efficiency [132]. The most 
simple definition of placental efficiency is the gram of fetus produced per gram of 
placenta [133]. It can also be measured as grams of fetus produced per unit area of 
placental exchange surface but this definition is used very rarely due to the difficulty 
to measure the exchange area in every placenta [134]. Indeed, in many species, a 
positive correlation has been shown between fetal weights near term to placental 
weight as a proxy measurement of surface area for transport of nutrients [134, 135]. 
In turn, size of the placenta, morphology, blood flow and abundance of transporters 
determine the nutrient transfer capacity of the placenta [136]. In addition, synthesis 
and metabolism of nutrients and hormones by uteroplacental tissue influence the 
rate of fetal growth [137]. Therefore, intrauterine growth can be affected by changes 
in any of the above mentioned placental factors [136, 138]. 
1.2.6 Role of angiogenic and antiangiogenic, and vasoactive factors in 
the development of pre-eclampsia  
The improper opening of the spiral arteries with subsequent placental hypoxia is 
thought to trigger the release of vasoactive factors from the placenta into the 
maternal circulation that finally causes systemic endothelial dysfunction and the full 
blown syndrome of pre-eclampsia (figure 15). Among other factors, soluble fms like 
tyrosine kinase 1(sFlt1) [139-141] appears to play a crucial role in the pathogenesis 
of pre-eclampsia. The Fms like tyrosine kinase receptor (Flt1) is highly expressed in 
the developing placenta and mediates the angiogenic effects of the vascular 
endothelial growth factor (VEGF) and the placental growth factor (PlGF) during 
invasion of the trophoblasts. Most of the Flt produced in the placenta during the later 
stages of normal gestation is a soluble form (sFlt), which is generated by alternative 
splicing of the Flt mRNA. The sFlt lacks the transmembrane and cytoplasmic 
domains of Flt1 and is released in large amounts into blood where it reduces the 
level of free VEGF and PlGF via soluble antagonism. In pre-eclampsia, sFlt is 
produced in large amounts already during early pregnancy.  
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Figure 15. Role of the antiangiogenic factor sFlt 1 in the maternal syndrome of pre-
eclampsia (adapted from [110]). 
This premature production of sFlt leads to an inappropriate decrease of VEGF 
and PlGF levels in the maternal circulation causing endothelial dysfunction of 
maternal vessels and the maternal pre-eclamptic syndrome [110]. Consecutively, 
blood pressure (BP) increases and the pre-eclamptic phenotype will develop 
damaging maternal organs such as kidneys, liver and brain [109, 110, 139-141]. 
In addition to VEGF signaling, also transforming growth factor (TGF) signaling 
appears to be affected in the vasculature of pre-eclamptic women. Clinical studies 
demonstrated that the soluble Endoglin (Eng) is elevated in the sera of pre-eclamptic 
individuals. Membrane bound Eng is a cell-surface coreceptor for transforming 
growth factor (TGF)- β 1 and TGF- β 3 that modulate the actions of TGF-β1 and 
TGF-β3 in endothelial cells and the syncytiotrophoblast.  Soluble Eng neutralizes 
circulating TGF- β1 before binding to its receptors and hence impairs TGF-β 
signaling in the vasculature [141] leading to activation of eNOS and vasodilation.  
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Figure 16. Hypothesis of pre-eclampsia pathophysiology (adapted from [110])  
Arterial hypertension in pre-eclampsia might be also explained, at least in 
part, by the observed increased plasma concentrations of vasoconstrictory 
substances (e.g. endothelin, thromboxane) and decreased plasma concentrations of 
vasodilatory mediators (e.g. prostacyclin, NO) in pre-eclamptic women [110]. Several 
lines of evidence have implicated the role of the renin–angiotensin system in the 
pathogenesis of pre-eclampsia. During normal pregnancy, plasma renin 
concentration, renin activity and angiotensin II levels are increased. However, 
pregnant women remain normotensive which is likely related to a reduced vascular 
responsiveness to angiotensin II [142]. In pre-eclampsia, the levels of plasma renin 
activity, the concentration of angiotensin II and aldosterone are decreased, but the 
pre-eclamptic patients manifest an exaggerated pressor response to angiotensin II 
[142, 143].  
Thus, the pathophysiology of proteinuria and hypertension in pre-eclampsia 
may involve the imbalanced expression of a variety of vasoactive substances 
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including VEGF, prostaglandins, thromboxane and angiotensin II. The schematic 
figure 16 summaries a unifying hypothesis of pre-eclampsia pathophysiology. 
1.2.7 Possible role of aldosterone in the development of the                        
pre-eclamapsia   
Normal pregnancy is characterized by a marked expansion of plasma and 
extracellular volume associated with changes in renal hemodynamics as well as in 
the circulating level of adrenal steroid hormones [144, 145], which likely help to adapt 
the maternal circulation to the increasing blood and substrate requirements of the 
growing placenta and fetus. Consistently, plasma aldosterone concentrations 
increase during normal pregnancy coinciding with plasma volume expansion [146, 
147]. In pregnancies later destined for pre-eclampsia, a reduced plasma volume 
precedes the onset of the disease [147-149] while plasma aldosterone concentration 
and renin activity are paradoxically suppressed [150]. This observation suggested 
pre-eclampsia to be caused or aggravated by an inadequate balance of extracellular 
volume and the activity of the renin-angiotensin-aldosterone system. As a substantial 
group of pre-eclamptic women show reduced aldosterone synthase enzyme 
(Cyp11b2 gene) activity [151], aldosterone deficiency was implicated to play an 
important role in the pathogenesis of pre-eclampsia. Aldosterone deficiency may 
lower extracellular volume and increase thereby the risk of placental hypoperfusion 
[151] with subsequent release of vasoactive factors leading to pre-eclampsia. The 
possible role of aldosterone was further evidenced by the finding that loss- and gain-
of function due to distinct gene variants of the Cyp11b2 may predispose for and 
protect from pre-eclampsia, respectively. In fact, the V386A variant of Cyp11b2  
gene, which causes a deficiency in the rate-limiting step of aldosterone synthesis, 
namely the 18-hydroxycorticosterone methyl oxidase activity [152], was observed 
solely in a subgroup of pre-eclamptic women, but never in normal pregnant women 
[151]. In contrast, the gain of function variants of the Cyp11b2 gene, SF-1 and Int2 
(C), which have been shown to be associated with hypertension in non-pregnant 
women  [153], apparently reduce the risk of developing pre-eclampsia [154]. 
Recently, observations by Gennari-Moser et al. [5] suggest a role of aldosterone for 
fetal perfusion and also for placental growth. Taken together, these studies propose 
a role of aldosterone availability for placental size, fetal perfusion and also the 
development of pre-eclampsia. 
39 
 
1.2.8 Different components of aldosterone effector mechanism 
expressed in placenta 
The following figures 17 gives an overview on the different placental cell types 
involved in the development of the placenta. 
 
Figure 17. Development of the placenta from the embryonic day E 3.5 to E 12.5 
(adapted from [155]). 
 
The syncytiotrophoblast acts as a transporting barrier that regulates the 
transfer of nutrients, solutes and water between maternal and fetal blood. In the 
human trophoblast, expression of the mineralocorticoid receptor (MR) and 11β-
HSD2 mRNA have been detected [156]. In addition, MR protein was 
immunolocalized to human syncytiotrophoblast and cytotrophoblast cells, and 11β-
HSD2 was found in the syncytiotrophoblast  [20]. Driver et al. [157] demonstrated 
that primary cytotrophoblast cell cultures express the Na+/K+-ATPase (α1 and β1 
subunits), α- and γ-subunits of ENaC and the Sgk1. Sgk1 was strongly and rapidly 
induced by corticosteroids (aldosterone and dexamethasone). Aldosterone induced 
Sgk1 activation was not inhibited by a GR antagonist indicating the presence of 
functional MR receptors in the placental trophoblast cells. Placental 11β-HSD2 may 
protect the MR in a fashion analogous to classical mineralocorticoid target tissues to 
modulate trophoblast sodium transport [156].  Significantly decreased 11β-HSD2 
mRNA expression levels were observed in placentas of patients with pre-eclampsia 
[158]. 
In syncytiotrophoblasts from normal placenta, ENaC was present on the 
apical membrane but not detected in pre-eclamptic placenta on mRNA and protein 
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level. In the BeWo cell line, a model of human syncytiotrophoblasts, ENaC was 
found and its expression is regulated by aldosterone, vasopressin, progesterone and 
estradiol [159]. Some evidence exists supporting the hypothesis that ENaC channels 
are required for the migration of BeWo cells [160]. Recently the  role of ENaC 
proteins in the migration of vascular smooth muscle cells (VSMC) has been 
demonstrated in cell culture [161]. In sheep low aldosterone levels resulted in 
reduced placental weight, adverse fetal outcome and up-regulation of  VEGF in 
placenta [162]. VEGF stimulates aldosterone production in cultured adrenal and 
endothelial cells (unpublished data from Markus Mohaupt). In vitro studies suggest 
that aldosterone stimulates trophoblast proliferation [5]. These experiments suggest 
that VEGF stimulates aldosterone production via the adrenal gland and aldosterone 
may have a role in trophoblast proliferation/migration and in placental development. 
1.2.9 High salt diet during pregnancy may affect blood pressure and 
pregnancy outcome  
Aldosterone is closely linked to salt reabsorption. Of interest, an old clinical study 
forwards the observation of a reduced number of pre-eclampsia and fetal death on a 
high salt diet [163]. In addition, in a hypertensive woman homozygous for the V386A 
mutant of Cyp11b2 and low aldosterone availability, salt supplementation lowered 
BP throughout pregnancy [164]. In contrast, in pre-eclampsia, the benefits of salt 
supplementation are still controversial and a recent meta-analysis did not show any 
beneficial impact [165]. 
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2 AIMS OF THE STUDY 
2.1 Role of aldosterone in renal potassium excretion 
Previous observation by Muto et al. [166] on isolated perfused CCD of 
adrenalectomized rabbits suggested an aldosterone-independent mechanism of K+ 
secretion on high K+ diet.  In this study, increased apical Na+ and K+ channels 
currents were observed on high K+ diet in adrenalectomized rabbits. Another studies 
in adrenalectomized rats on high K+ diet also showed an increased number of 
conducting Na+ channels suggesting that there are factors other than aldosterone 
that regulate ROMK-like SK channel, Na+ channels and Na+/K+ pumps on high K diet 
[167]. Moreover, the presence of a local renal aldosterone system and its regulation 
by salt has been suggested [168, 169]. Obviously the presence of a local renal 
aldosterone system was not considered in previous studies. Therefore, to further 
address the role of aldosterone for the renal and colonic control of K+ homeostasis, 
we used the aldosterone synthase knockout (AS-/-) mice as an in vivo model without 
any endogenous aldosterone production.   
2.2 Role of aldosterone in pregnancy 
Available literature suggests that aldosterone plays an important role in pregnancy. 
However, it is not clear whether aldosterone deficiency alone can lead to 
compromised pregnancy, IUGR, or preeclampsia and whether aldosterone 
deficiency can be counterbalanced by a high salt diet. To address these questions 
we used aldosterone synthase deficient knockout mice (AS-/-) [9]. Monitoring of 
pregnancy in AS-/- mice for systolic BP, proteinuria, and pregnancy outcome was 
performed to assess the effects of aldosterone in murine pregnancy. Detailed 
analysis of placentas and pups also examined the role of aldosterone in the 
development of IUGR and placental efficiency.  
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3 MATERIAL AND METHODS 
3.1 Role of aldosterone in renal potassium excretion 
3.1.1 Animal model 
All experiments were performed on aldosterone synthase wild type (Cyp11b2, AS+/+) 
and aldosterone synthase-deficient (AS-/-) mice with a inbred129Sv genetic 
background [170]. This mouse model was generously provided by Prof. Oliver 
Smithies, University of North Carolina, Chapel Hill, NC, USA [9]. Age-matched male 
AS+/+ and AS-/- mice (8 to 14 weeks) were used for all experiments. All experiments 
were performed according to Swiss Animal Welfare laws and approved by the local 
veterinary authority (Veterinäramt Zürich). All animals received standard rodent chow 
GLP 3433 (PROVIMI KLIBA, Kaiseraugst, Switzerland).  
 3.1.2 Metabolic cage experiments 
To analyze adaptive physiological changes in mice, animals were kept individually in 
metabolic cages (Tecniplast, Buguggiate, (VA) Italy). This type of cages allows an 
exact monitoring of individual food and water consumption as well as urine and 
faeces collection. Mice were adapted to metabolic cages for 3 days before the actual 
measurements. During the experiment bodyweight, consumption of food and water 
as well as urine volumes and faeces were monitored and collected daily. 24 hour 
urine was collected under mineral oil to avoid evaporation. At the end of the 
experiments urinary electrolytes (Na+, K+, Ca2+,Mg2+,Cl-,SO4-) were measured by ion 
chromatography (Metrohm ion chromatograph, Herisau, Switzerland) and urine 
creatinine was measured by the Jaffe method [171].  
3.1.3 Experimental protocol for dietary potassium loading 
Four different potassium (K+) diets were used in this study. Control diet (0.8% K; 
standard powder food), 2% K+  diet (2.2 g of KCl + 97.8 g standard powder food), 3% 
K+ diet (4.2 g KCl + 95.8 g standard powder food) and 5% K+ diet  (8 g of KCl + 92 g 
standard powder food). Powdered food with the appropriate amount of KCl was 
mixed with milliQ water in 1:1 proportion (50 g food + 50 ml water) to prepare wet 
diets. AS+/+ and AS-/- mice were divided into four different groups: Control group 
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(Control diet, n = 5), 2% K+ diet group (n = 7), 3% K+ diet group (n = 7) and 5% K+ 
diet group (n = 5). After an adaptation phase in the metabolic cage for 3 days all 
mice were fed for one day with control diet (time point 0) followed by two days on the 
experimental diets varying in their K+ contents. At the end of the experiment, mice 
were anesthetized with ketamine/xylazine (Narketan (Vétoquinol, CH): 65 mg/kg BW; 
Xylazin (Streuli, CH): 13 mg/kg BW), and heparinized venous blood from the 
abdominal vein was collected and analyzed immediately for pH, blood gases, and 
electrolytes on a Radiometer ABL 505 (Radiometer, Copenhagen, Denmark) blood 
gas analyzer. Serum was collected and frozen until further analysis. Kidneys were 
harvested, immediately frozen in liquid nitrogen, and stored at -80oC until mRNA 
and/or protein extraction.  
3.1.4 Changes in tubular workload 
To assess the functional activity of ENaC and NCC in the kidney in vivo, AS+/+ and 
AS-/- mice were treated with the diuretics amiloride and thiazide, respectively. Mice 
were kept in metabolic cages and fed one day with control diet and 2 days with 2% 
K+ diet to get the control physiological values. After these three days, mice were 
divided into control groups and treatment group (injection of diuretics). At the end of 
the experiment, the urinary bladder was emptied by massage, and mice from control 
groups were treated with vehicles (0.9% saline i.p., AS+/+ n = 9, AS-/- n = 8 or 
dimethyl sulfoxide (DMSO) i.p., AS+/+ n = 8, AS-/- n = 9; Control-group), and mice 
from the treatment groups were injected with either amiloride (5 µg amiloride/g body 
weight in 200 µl of 0.9% saline solution i.p.; Amiloride group; AS+/+ n = 11, AS-/- n = 
9) or with hydrochorthiazide (50 µg hydrochlorothiazide/g body weight in  200 µl 
DMSO; Thiazide group; AS+/+ n = 9, AS-/- n = 9). After 4 hours, urine was collected 
from urine collector and by emptying urinary bladder by massage. Urine was 
analyzed for electrolytes including Na+ and K+. 
3.1.5 Role of angiotensin II in renal adaptation to high potassium diet 
To assess the role of angiotensin II in compensating the lack of aldosterone, mice 
were given the AT1 receptor blocker losartan. AS+/+ and AS-/- mice were individually 
kept in metabolic cages. After 3 days of adaptation on control diet and one and half 
days on  2 % K+ diet, mice were divided in two groups and received in the evening 
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either a s.c. injection of vehicle (milliQ water; Control group; n = 4) or losartan        
(10 mg/kg body weight in 50µl milliQ; losartan group; n = 5). At the end of the 
experiment, mice were anesthetized and heparinized venous blood was collected 
from the abdominal vein and analyzed immediately for electrolytes. Urine was 
collected under mineral oil and analyzed for creatinine, and electrolytes including 
Na+ and K+.   
3.1.6 Analysis of the urinary concentration capability of AS+/+ and AS-/- mice 
To examine the urinary concentrating mechanism, mice were kept in metabolic 
cages for 5 days. To have the same water intake in both groups, a special agar diet 
was prepared that comprised the same volume of water but an amount of food that 
matched the one recorded before to be eaten daily by the AS+/+ and AS-/- mice      
(40 mg of agar and 4 ml of water per 1 g and 1.33 g of standard powdered food for 
AS+/+ mice and AS-/- mice, respectively). After 3 days of adaptation to the 0.8% K+ 
agar diet, mice were given 2% K+ in the agar diet. After two days, the urinary bladder 
was emptied by massage and mice were divided into two groups and injected s.c. 
with either vehicle (0.9% saline; control group; n = 5) or with the modified form of 
vasopressin called as desmopressin (DDAVP) (Sigma) (1 ng/g of body weight in 100 
µl of 0.9% saline solution; DDAVP group; n = 5). Urine was collected before injection 
and 4 hr after the treatment by emptying the urinary bladder by massage. Urine 
osmolarity was measured by freezing point depression (Osmometer, Roebling). At 
the end of the experiment, mice were anesthetized and heparinized venous blood 
was collected and analyzed immediately on a Radiometer ABL 505 (Radiometer, 
Copenhagen, Denmark) blood gas analyzer for plasma Na+ and K+ concentration. 
3.1.7 RNA extraction from the kidney 
Snap frozen kidneys (5 kidneys per group) were homogenized in RLT Buffer 
(Qiagen) supplemented with 2-mercaptoethanol to a final concentration of 1%. Total 
RNA was extracted from 200 µl aliquots of each homogenized sample using RNeasy 
Mini Kit (Qiagen) according to the manufacturer’s instructions. Quality and 
concentration of the isolated RNA preparations were measured by ND-1000 
spectrophotometer (NanoDrop Technologies). Total RNA samples were stored at      
-80oC until further use. 
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3.1.8 Quantitative Real-time PCR 
Each RNA sample was diluted to 100 ng/µl and 3 µl was used as a template for 
reverse transcription using the TaqMan Reverse Transcription Kit (Applied 
Biosystems, Forster City, CA). Quantitative real time (qRT-PCR) was performed on 
the ABIPRISM 7500 Sequence Detection System (Applied Biosystem). Primers for 
the NCC (Slc12a3) were designed using online Primer 3 software. Sequences of 
primers and probes are as follows: NCC forward 5’-TAG ACC CCA TCA ATG ACA 
TCC-3’ and reverse 5’-AGG TAG TTG GCA AAG GAG ACC-3’ (accession number: 
NM_001205311); BK β1 forward 5’-CCA GCG GAG ACC CAG AGA-3’, reverse 5’-
GGG CCA TCA CCA GCT TCT T-3’and probe 5’-CTA AAT GAC TGT TGC CTC 
CAG TGG CCA-3’ (accession number: NM_031169); BK β2 forward 5’-GCT GCG 
CTC CTA CAT GCA-3’, reverse 5’-GCC CAC AGC TGA AGG AAC AG-3’ and probe 
5’-AGC GTG TGG ACA GAA GAA GCC CAG TGT-3’ (accession number: 
NM_028231); BK β4 forward 5’-AAC TCC AGG GCG CTG CTA-3’, reverse 5’-CTC 
TTA CAG GGC GGG ATA TAG GA-3’ and probe 5’-ACA GCG ACC AGC ACC AGC 
TCC TG-3’ (accession number: NM_021452). Primers for hypoxanthine guanine 
phosphoribosyl transferase (HPRT) as a housekeeping gene were designed using 
Primer Express software from Applied Biosystem. Primer sequences for HPRT were 
forward 5’-TTA TCA GAC TGA AGA GCT ACT GTA AGA TC-3 and reverse 5’-TTA 
CCA GTG TCA ATT ATA TCT TCA ACA ATC-3’ (accession number: NM_013556) 
as described previously [172].  Specificity of the primers was - tested in a standard 
PCR and always resulted in a single product of the expected size on 2% agarose 
gel. Real time PCR reactions were performed for NCC using the iQ SYBR Green 
Supermix (Bio-rad). ROX Passive reference Dye (Bio-rad) 3.3 µl/1.25 ml of iQ SYBR 
Green Supermix was added. Briefly, 3 µl cDNA, 0.8 µl of each primer (10 µM), 5.4 µl 
RNase free water, 10 µl iQ SYBR Green Supermix reached 20 µl final reaction 
volume. Real time PCR reactions were performed for BKβ1, BKβ2 and BKβ4 using 
TaqMan Universal PCR Mastermix (Applied Biosystem). Briefly, 3 µl cDNA, 0.8 µl of 
each primer (25 µM), 0.4 µl of labeled probe, 6 µl of RNAse free water and 10 µl of 
TaqMan Universal PCR master mix reached total volume of 20 µl of final reaction 
volume. Reaction conditions were: denaturation at 95oC for 10 min followed by 40 
cycles of denaturation at 95oC for 15 s and annealing/elongation at 60oC for 60 s 
with auto ramp time. For PCR reactions using the iQ SYBR Green Supermix last 
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step is followed by dissociation stage (95oC for 15 s, 60oC for 15 s followed by slow 
ramp to 95oC). All reactions were run in duplicate. The expression of gene of interest 
was calculated in relation to HPRT. Relative expression ratios were calculated as R 
= 2[Ct(HPRT/_-actin)_Ct(test gene)]. 
3.1.9 Membrane preparation and western blot analysis 
Total membrane proteins were prepared as described previously [173]. After 
measurement of the protein concentration (Bio-rad Dc Protein Assay, Bio-rad, 
Hercules, CA, USA), 50 µg of crude membrane proteins were solubilized in Laemmli 
sample buffer, and SDS-PAGE was performed on 8% polyacrylamide gels. For 
immunoblotting, the proteins were transferred electrophoretically to nitrocellulose 
transfer membrane (PROTRAN 0.2 µM, Whatman GmbH, Dassel, Germany). After 
incubation with Odyssey blocking buffer, (Li-COR) for 60 min, the blots were 
incubated with the respective primary antibodies diluted in Odyssey blocking buffer 
overnight at 4oC.The primary antibodies used are listed in Table 1.  
Table 2. Antibodies used for immunohistochemistry and western blotting 
  Dilution  
Antibody Host WB IF Source 
ROMK1 Rabbit 1:800 1:4,000 Alomone 
αENAC 
βENaC 
γENaC 
NCC 
pNCCT53 
pNCCT58 
pNCCs89 
AQP2 
Rabbit 
Rabbit 
Rabbit 
Rabbit 
Rabbit 
Rabbit 
Rabbit 
Rabbit 
1:5000 
1:10,000 
1:10,000 
1:8000 
1:1000 
1:2000 
1:4000 
1:10,000 
1: 5,000 
1:40,000 
1:40,000 
1:10,000 
1:15,000 
 
 
J.Loffing 
J.Loffing 
J.Loffing 
J.Loffing 
R. Fenton 
R.Fenton 
J.Loffing 
J.Loffing 
β actin 
Calbindine D28k 
Rabbit 
Mouse 
1:10,000  
1:10,000 
Sigma 
Swant (CH) 
BK Mouse 1:10,000  NeuroMab 
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After overnight incubation, the membranes were washed three times with 
phosphate buffer saline containing 0.1% Tween 20, and incubated with the 
fluorescent secondary antibody (goat anti-rabbit IRdye 800 1:10,000, or goat anti 
mouse IRDye 680, 1:20,000, Li-COR, Nebraska, USA or from Rockland, 
Gilbertsville, PA) for 1 h at room temperature. After washing the membranes three 
times, the protein signal was detected by scanning the membrane with the Odyssey 
Infrared Imaging System (Li-COR Biosciences). All images were analyzed using 
analysis software provided with the system to calculate the protein of interest/actin 
ratio. 
3.1.10 Immunohistochemistry 
For immunohistochemistry, AS+/+ and AS-/- mice of the different experimental groups 
(n = 5 each) were anesthetized with ketamine/xylazine (Narketan (Vétoquinol, CH): 
65 mg/kg BW; Xylazin (Streuli, CH): 13 mg/kg BW) and the kidneys were fixed by 
intravascular perfusion via the abdominal aorta [174]. The fixation solution contained 
3% paraformaldehyde (Sigma-Aldrich, USA) in 0.1 M phosphate buffer. After 5 min 
of fixation kidneys were rinsed for 5 min with 0.1 M phosphate buffer. 2 mm thick 
kidney slices were subsequently mounted on thin cork slices, frozen in liquid 
propane and stored at -80°C until further use. 
For immunohistochemistry, kidneys were cut into 4 - 5 µm thin sections in a 
cryostat (Microm, Leica, CH), and mounted on chrome-alum/gelatin coated glass 
slide. After 10 min blocking of unspecific binding sites by 10% normal goat serum, 
sections were incubated over night with the primary antibodies diluted in 1% 
PBS/BSA. Overnight incubation took place at 4°C in a humidified chamber. Antibody 
dilutions are given in table 1. After repeated rinsing of the sections with PBS, binding 
sites of the primary antibodies were detected with either Cy3 conjugated goat anti 
rabbit antibody or FITC conjugated goat anti mouse antibody (Jackson Immuno 
Research Laboratories, USA). After three times rinsing, the slides were mounted in 
Glycergel (DAKO, USA) with 2% 1,4-Diazabicyclo[2.2.2.]octans (Sigma-Aldrich, 
USA) to avoid fading of the signal. Sections were studies by epifluorescence (Leica 
DM6000; Leica D) and analyzed by Leica AF6000 system (Leica D). 
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3.1.11 Ussing chamber experiments 
Male mice kept on the respective K+ containing diets were sacrificed by cervical 
dislocation. The distal part of the colon was isolated and rinsed in ice cold ringer 
solution. Only the distal 1.5 cm of the intact mouse colon was then mounted in an 
Ussing Chamber. The two halves of the chamber were continuously perfused by a 
bubble lift system. The solutions on the two sides were symmetrical and with the 
following composition (in mM): NaCl 120; NaHCO3 25; K2HPO4 1.6; KH2PO4 0.4; Ca-
gluconate 1.3; MgCl2 1; D-glucose 5, indomethacine (5 µM). The reservoirs were 
bubbled with carbogen (5% CO2 and 95% O2) and kept at 37
oC by water jackets.  
Initially, tetrodotoxin (TTX, 1 µM) was added to the serosal side to inhibit possible 
secretory activation by the enteric nervous system or other autonomous nerve cells.   
Experiments were performed in a setup where the transepithelial voltage was 
clamped to “zero” (Physiological Instruments, USA). The apertures of the clamped 
chambers were 0.283 cm2. After mounting the tissues and an equilibration period of 
30 min, amiloride (100 µM) was added to the mucosal perfusate to obtain a value of 
amiloride-sensitive short circuit current (ΔIsc(amil)), a measure of electrogenic ENaC-
mediated Na+ absorption. After additional 5 min. BaCl2 (5 mM) was added also to 
the mucosal perfusate to obtain a value of Ba2+-sensitive short circuit current 
((Isc(Ba
2+)), a measurement of electrogenic BK-mediated K+ secretion. 
3.1.12 Statistical analysis 
Results are expressed as mean ± SEM. All data were tested for significance using 
unpaired and paired Student’s test where appropriate. Only values with p < 0.05 
were considered as significant. 
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3.2. Role of aldosterone in pregnancy 
3.2.1 Animals 
All experiments were performed on inbred 129 SvEv genetic background 
aldosterone synthase wild type (AS+/+) and aldosterone synthase-deficient (AS-/-) 
female mice. Mice were bred in our own animal facility. All experiments were 
performed according to Swiss Animal Welfare laws and approved by the local 
veterinary authority (Kantonales Veterinäramt, Zürich). Unless indicated otherwise, 
animals were fed standard rodent chow (3430, KLIBA NAFAG, Kaiseraugst, 
Switzerland) with free access to normal tap water.  
3.2.2 Study design and treatment 
Age matched female AS+/+ and AS-/- mice, between 3.5 to 6.5 months old, were used 
for experiments. Animals were divided into two groups, a control group and an 
experimental group. In the control group, AS-/- male were mated with AS+/+ female 
mice, whereas in the experimental group, AS+/+ male mice were mated with AS-/- 
females to generate only heterozygous pups to have the same genotype for all pups. 
Both groups were fed with either the standard rodent chow powder, (3433 KLIBA 
NAFAG, Kaiseraugst, Switzerland) containing 0.20% Na+ and 0.36% Cl- (AS+/+ n = 9 
and AS-/- mice n = 9) or with standard diet supplemented with NaCl (high salt diet, 
5% NaCl) (AS+/+ n = 6-8 and AS-/- mice n = 8-10). To feed the mice with high salt 
diet, 100 g of standard rodent chow powder was mixed with 5 g NaCl and then mixed 
with an equal volume of deionised water to moisten the food for feeding. Male and 
female mice were kept together in individual cages for breeding and female mice 
were controlled daily in the early morning for the presence of copulation plugs and 
the following day was considered as gestational day 1. Systolic blood pressure 
(SBP) was measured in female mice using the tail cuff method (see below). In 
second set of experiments mice were fed either the control diet (AS+/+ n = 8, AS-/- n = 
15) or high salt diet (5% NaCl) (AS+/+ n = 6, AS-/- n = 9) and sacrificed on day 18 of 
pregnancy by cervical dislocation. The number and weight of the pups and the 
placentas were measured, and tissues collected for further analysis. Placentas were 
collected and rapidly frozen in liquid nitrogen and stored at -80oC for RNA extraction. 
Some placentas were fixed in 4% paraformaldehyde for further histological analysis.  
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3.2.3 Tail cuff blood pressure measurements 
SBP was measured by a non-invasive computerized tail cuff method (BP2000, 
Visitech Systems, Apex, NC, USA) as described previously [175]. Mice were 
adapted for 5 days before the start of the study. Blood pressure was measured daily 
between 1 pm to 5 pm. Averages of systolic BP with a standard deviation of less 
than 10 mmHg were considered to be stable measurements and were used for 
further analysis. SBP from female mice on control diet was measured on control 
conditions 2 to 3 days before pregnancy and from day 1 of pregnancy until the end of 
pregnancy up to 21 days. Mean SBP was calculated from each day’s average SBP 
measurements. SBP of animals in the high salt diet experiments was measured first 
on control diet, then from day 4 to 6 of high salt diet. Thereafter, female mice were 
kept together with male mice for mating and SBP was measured at gestational days 
5 to 7 and days 15 to 17. Mean SBP was calculated from 3 days of average SBP 
measurements. 
3.2.4 Urinary protein concentration measurement 
Spot urines were collected from female mice during pregnancy daily by gentle 
massage of the urinary bladder. Total urinary protein concentration was measured 
with a standard protein assay kit (Bio-rad Dc Protein Assay, Bio-rad, Hercules, CA, 
USA). Urinary creatinine concentration was measured by the Jaffe method [171]. 
3.2.5 RNA extraction 
Snap frozen placentas (5 placentas per group) were homogenized in RLT buffer 
(Qiagen, Hilden, Germany) supplemented with 2-mercaptoethanol to a final 
concentration of 1%. Total RNA was extracted from 200 µl aliquots of each 
homogenized sample using RNeasy Mini Kit (Qiagen, Hilden, Germany) according to 
the manufacturer’s instructions. Quality and concentration of the isolated RNA 
preparations were measured on a ND-1000 spectrophotometer (Thermo Fischer 
Scientific Inc., Wilmington, DE, USA). Total RNA samples were stored at -80oC until 
further use. 
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3.2.6 Semi-quantitative Real-time PCR 
Each RNA sample was diluted to 100 ng/µl and 3 µl was used as a template for 
reverse transcription using the TaqMan Reverse Transcription Kit (Applied 
Biosystems, Forster City, CA). Quantitative real time (qRT-PCR) was performed on 
the ABIPRISM 7500 Sequence Detection System (Applied Biosystem, Foster City, 
CA, USA). Primers for vascular endothelial growth factor (VEGF), soluble fms-like 
tyrosine kinase-1 (sFlt-1), and the hypoxia inducible factor 1α (HIF1α) were designed 
using Primer 3 online software, whereas primers for hypoxanthine guanine 
phosphoribosyl transferase (HPRT) as housekeeping gene were designed using 
Primer Express software from Applied Biosystem. The primers and probes used from 
Applied Biosystem are monocyte chemo-attractant protein 1 MCP-1 (Mm00441242) 
and Tumor Necrosis Factor 1alpha TNFα (Mm99999068). Sequences of primers 
designed by ourselves are as follows: VEGF forward 5’-CAG GCT GCT GTA ACG 
ATG AA-3’ and reverse 5’-GCA TTC ACA TCT GCT GTG CT-3’ (accession number:  
NM_009505.4); sFlt forward 5’-GGG AAG ACA TCC TTC GGA AGA-3’ and 
reverse 5’-TGT GGT ACA ATC ATT CCT CCT G-3’ (accession number:  D88690);  
HIF1α forward 5’-ATC TCG GCG AAG CAA AGA G and reverse    5’-CTG TCT AGA 
CCA CCG GCA TC-3’ (accession number:  NM_010431); HPRT  forward 5’-TTA 
TCA GAC TGA AGA GCT ACT GTA AGA TC-3 and reverse 5’-TTA CCA GTG TCA 
ATT ATA TCT TCA ACA ATC-3’ (accession number: NM_013556).  The specificity 
of the primers was first tested in a standard PCR that resulted in a single PCR 
product of the expected size on 2% agarose gels. Real time PCR reactions were 
performed using the iQ SYBR Green Supermix (Bio-rad, Hercules, CA, USA). ROX 
Passive reference Dye (Bio-rad, Hercules, CA, USA) 3.3 µl/ 1.25 ml of iQ SYBR 
Green Supermix was added. Briefly, 3 µl cDNA, 0.8 µl of each primer (10 µM), 5.4 µl 
RNase free water, 10 µl iQ SYBR Green Supermix were mixed to 20 µl final reaction 
volume. Reaction conditions were: denaturation at 95oC for 10 min followed by 40 
cycles of denaturation at 95oC for 15 s and annealing/elongation at 60oC for 60 s 
followed by dissociation stage (95oC for 15 s, 60oC for 15 s followed by a slow ramp 
to 95oC). All reactions were run in duplicate. The expression of gene of interest was 
calculated in relation to HPRT. Relative expression ratios were calculated as R = 
2[Ct(HPRT/-actin)_Ct(test gene)]. 
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3.2.7 Histology  
Placentas were fixed by immersion in 4% paraformaldehyde (Applichem, Darmstadt, 
Germany). After tissue processing and embedding in paraffin, 5 µm sections were 
prepared. Paraffin sections were stained with hematoxylin-eosin (H&E) and scanned 
with the Mirax Midi Slide Scanner microscope (Zeiss, Jena, Germany).   
3.2.8 Immunoblotting 
Placentas, stored at -80°C, were homogenised in ice cold homogenisation buffer 
(0.27 M sucrose, 2 mM EDTA, 0.5% NP40 prepared in 1x buffer A supplemented 
with protease and phosphatase inhibitor cocktails (Roche, Mannheim, Germany) 
(buffer A: 0.6 M KCl, 150 mM NaCl, 150 mM HEPES, pH 7.5,). Homogenates were 
overlaid on a sucrose cushion (30% w/v sucrose, 2 mM EDTA, pH 8 prepared in 1x 
buffer A) and centrifuged at 3,000 rpm for 10 mins at 4°C.  After centrifugation, 
supernatant obtained were stored as a cytoplasmic fraction, and pellets of nuclei 
were resuspended in 1x nuclei extraction buffer (20 mM HEPES, pH 7.5, 400 mM 
NaCl, 1 mM EDTA, pH 8) and incubated for 15 minutes on ice with intermittent 
vortexing. Solubilised nucleated pellet fractions were centrifuged again at 15,000 
rpm for 5 min at 4°C and supernatant collected as nuclear protein fraction. Protein 
concentration was measured with a protein assay kit (Bio-rad protein assay, Munich, 
Germany). 60 to 80 µg of proteins were solubilised in 5X Laemmli sample buffer and 
run on 8% polyacrylamide gels. Briefly, protein was separated by SDS-PAGE, 
transferred on nitrocellulose membrane by the wet transfer method and incubated 
overnight with the following primary antibodies: rabbit polyclonal anti-HIF1α (1:1000, 
Novus Biologicals) and mouse monoclonal β-actin (1:10,000, Sigma). After washing, 
nitrocellulose membranes were incubated with anti-rabbit secondary fluorescent 
antibody (goat anti-rabbit IRdye 800 1:10,000, or goat anti mouse IRDye 680, 
1:20,000, Li-COR, Nebraska, USA). After washing the membranes three times, the 
protein signal was detected by scanning the membrane with the Odyssey Infrared 
Imaging System (Li-COR Biosciences). All images were analyzed using analysis 
software provided with the system to calculate the protein of interest/actin ratio. 
53 
 
3.2.9 Statistical analysis 
Results are expressed as mean ± SEM. All data were tested for significance using 
paired or unpaired Student’s test or one way ANOVA analysis followed by Tukey’s 
multiple comparison and Bonferroni’s post test where appropriate. P<0.05 was 
considered statistically significant. 
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4 RESULTS 
4.1 Aldosterone dependent and independent regulation of renal K+-
excretion 
4.1.1 Response to high K+ loading 
To assess the tolerance of AS-/- mice to high K+ load, mice were given different K+ 
diets. On control (0.8% K+) and on 2% K+ and 3% K+ diets, AS-/- mice ingested 
slightly, but not significantly more food than AS+/+ mice. With 5% K+ diet food intake 
significantly decreased in AS-/- compared to AS+/+ mice (figure 18A). AS-/- mice drank 
significantly more water compared to AS+/+ on control (5.1 ± 0.3 ml vs. 4.3 ± 0.2 ml, p 
= 0.04), 2% K+ diet (8.0 ± 0.6 ml vs. 6.4 ± 0.4 ml, p = 0.04), and on 3% K+ diet (8.4 ± 
0.7 ml vs. 5.5 ± 0.4 ml, p = 0.002). On 5% K+ diet, water intake was significantly 
decreased in AS-/- mice compared to AS+/+ mice (6.3 ± 1.0 ml vs. 9.9 ± 0.8 ml, p = 
0.02). As expected, in AS-/- mice urinary volume per 24 h was elevated already on 
control diet and was significantly higher on 2% K+ and 3% K+ diet compared to AS+/+  
mice on the corresponding diets. On 5% K+ diet, urinary volume was significantly 
decreased in the AS-/- mice reflecting the diminished water intake (figure 18B). 
Plasma Na+ concentrations revealed no difference among the genotypes on different 
K+ diets. In contrast, plasma K+ concentrations on 2% K+ and 3% K+ diets was 
slightly elevated in knockout mice and culminating to a hyperkalemic situation in AS-/- 
mice on 5% K+ diet with significantly higher plasma K+ levels than the corresponding 
AS+/+ mice (figure 18C and 18D). To examine the ability of the kidney to adapt to 
changes in dietary K+ load, 24 h urinary electrolyte concentrations was measured by 
ion chromatography. Urinary Na+ excretion of AS-/- mice was slightly elevated on 
control and significantly higher on 2% K+ diet, but there was no difference on 3% K+. 
On 5% K+ diet, AS-/- showed a lower Na+ excretion than AS+/+ mice. Urinary K+ 
excretion parallels the observations seen for urinary Na+ excretion. AS-/- mice were 
able to excrete K+ in the urine on control diet, and even excreted significantly higher 
K+ on the 2% K+ diet compared to AS+/+ mice. However, on 3% K+ diet urinary K+ 
excretion in AS-/- mice was similar as in AS+/+ mice, and on 5% K+ diet, K+ excretion 
was significantly decreased in AS-/- mice indicating their inability to adapt to very high 
K+ load (figure 18E and 18F). 
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Figure 18. Response of AS+/+, wild type mice, (open bars); and AS-/-, aldosterone 
synthase-deficient mice, (filled bars) to control (0.8% K+), 2% K+, 3% K+, and 5% K+ 
loading. Mice were kept in metabolic cages and urine and blood electrolytes were 
measured. Physiological responses in relation to food intake over 24 h (A), urine excretion 
over 24 h (B), blood Na+ concentration (C) and  blood K+ concentration (D) at the end of 
experiment after 2 days of diet, urine Na+ excretion over 24 h (E) and  urine K+ excretion 
over for 24 h (F) are shown. Measurements were performed after 2 days of K+ diet. n = 5-7 
mice per group. Values are mean ± SEM. * p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001. 
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4.1.2 Effect of high K+ diet on distal nephron K+ and Na+ channels: Increased 
apical expression of ROMK and maintained ENaC cleavage in AS-/- mice on 2% 
K+ diet 
In mice on 0.8% K+ diet, immunoblots showed significantly decreased protein 
abundances for the uncleaved (90kDa) band of α-ENaC in AS-/- mice, and no 
significant difference in protein abundance for β- and γ-ENaC between genotypes 
(figure 19).  
 
Figure 19. Protein abundance of ENaC in AS+/+ and AS-/- mice on 0.8% K+ (control) diet. 
Immunoblots for α-, β- and γ-ENaC subunit in total membrane fractions from mouse kidneys. 
All membranes were reprobed for β-actin and all data were normalized against β-actin. Bar 
graphs summarizing data from immunoblotting. n = 5 mice per group. +/+, wild type mice;      
-/-, aldosterone synthase-deficient mice. Values are mean ± SEM. * p ≤ 0.05. 
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The physiological data suggested that the AS-/- mice are able to adapt to a 
moderate increases in dietary K+ intake, but cannot stand a high dietary K+ load (5% 
K+). Therefore, we concentrated in the following experiments mainly on the 2% K+ 
diet and elaborated in more detail the aldosterone-dependent and independent-
mechanisms of the homeostatic adaptation of a dietary K+ load.  
First, we examined the regulation and expression of the ROMK in response to 
a dietary K+ load. Immunoblotting showed no significant difference in protein 
abundance for the glycosylated and the non-glycosylated forms of ROMK on 2% K+ 
diet. Immunostainings of kidney sections from 2% K+ diet mice showed ROMK 
localized to the apical membrane in PCs of the DCT and CNT in AS+/+ mice. 
Interestingly, in AS-/- mice, there was also apical localization of ROMK in the DCT 
and CNT with apparently stronger ROMK staining intensity compared to AS+/+ mice 
(figure 20). We also checked for an altered expression of the BK channel at protein 
level by using an antibody against the α-subunit. The BK channel could be only 
detected in brain samples, but was not detectable in kidney samples (figure 21A). 
We also examined the mRNA expression of the BK channel β1, β2 and β4 subunits 
in kidneys from mice of both genotypes (figure 21B). All subunits were weakly 
expressed in the kidney and no significant differences in the mRNA expression of BK 
subunits were revealed between AS+/+ and AS-/- mice.  
To test for the protein abundance of ENaC after 2% K+ diet loading, 
immunoblotting for the different ENaC subunits was done on total kidney proteins 
from AS+/+ and AS-/- mice  (figure 22A). Protein abundance for α-ENaC, both 
uncleaved (95 kDa) form and cleaved (30 kDa) form, was not significantly different 
between genotypes indicating maintained α-ENaC cleavage in AS-/- mice. 
Immunoblots for β-ENaC showed significantly increased protein abundance in AS-/- 
mice compared to AS+/+ mice. Protein abundance for the uncleaved (85 kDa) form of 
γ-ENaC in AS-/- mice was significantly increased compared to AS+/+ mice but did not 
reveal difference in protein abundance for the cleaved (70 kDa) form of γ-ENaC 
between the genotypes, again indicating maintained cleavage. These results 
suggest increased protein abundance for β- and γ- (85 kDa, uncleaved bands) ENaC 
and maintained α- and γ-ENaC cleavages in AS-/- mice. 
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Immunohistochemistry was used to determine whether the 2% K+ diet altered 
the segmental and/or subcellular distribution of α-, β- and γ-subunits of ENaC in AS-/- 
and AS+/+ mice (figure 22B). In the CNT, α-ENaC staining was localized to the apical 
membrane in AS+/+ mice and, interestingly, also in AS-/- mice whereas in the CCD, α-
ENaC was localized to the apical membrane in few cells in both genotypes. In AS+/+ 
mice, β- and γ-ENaC staining was localized to the apical membrane in the CNT, 
whereas staining in the CCD was mostly cytoplasmic. Interestingly, in AS-/- mice, β- 
and γ-ENaC staining was mostly cytoplasmic in the CNT and CCD. Nevertheless, in 
parallel with the western blot results, the signal intensity of β- and γ-ENaC staining 
was stronger in AS-/- mice. Thus, AS-/- mice show an increased abundance of β- and 
γ-ENaC protein, but these ENaC subunits are mostly cytoplasmically localized. On 
5% K+ diet, ROMK was localized to the apical membrane both in AS+/+ and AS-/- 
mice. In AS+/+ mice β-ENaC was localized to the apical membrane but was mostly 
cytoplasmic in AS-/- mice (figure 24).  
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Figure 20. Expression and subcellular distribution of the renal outer medullary 
potassium channel (ROMK) during 2% K+ loading in mouse kidney. (A) Immunoblotting 
for mature glycosylated (55 kDa) and core glycosylated (42 kDa) ROMK channel in total 
membrane fractions of kidneys. The membrane was reprobed for β-actin. n = 5 mice per 
group. (B) Immunolocalization of ROMK channels in distal convoluted tubule (DCT) and 
connecting tubule (CNT) in kidney sections. +/+, wild type mice;   -/-, aldosterone synthase-
deficient mice. 
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Figure 21. Expression of Ca+ activated large conductance K+ channel (BK) channel 
during 2% K+ loading. (A) Immunoblotting for BK channel protein in total membrane 
fractions from mouse kidney and brain samples with or without primary antibody. (B) Real 
time PCR was used to assess the mRNA expressions of β1, β2 and β4 subunits of BK 
channel. n = 6 mice per group. 
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Figure 22. Expression and subcellular localization of the epithelial sodium channel 
(ENaC) during 2% K+ loading in mouse kidney. (A) Immunoblotting for α-, β- and γ-ENaC 
subunits in total membrane fractions. All membranes were reprobed for β-actin and all data 
were normalized against β-actin. Bar graphs summarizing data from immunoblotting. n = 5 
mice per group. (B) Immunolocalization of α-, β- and γ-ENaC subunits in the connecting 
tubule (CNT) and cortical collecting duct (CCD) in kidney sections. +/+, wild type mice;   -/-, 
aldosterone synthase-deficient mice. Values are mean ± SEM. * p ≤ 0.05. 
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On 5% K+ diet (figure 23), α-ENaC protein abundance for the uncleaved (90 
kDa) and cleaved (30 kDa) bands, was significantly lower in AS-/- than in AS+/+ mice. 
No significant difference in protein abundance for the β-ENaC subunit was observed, 
whereas γ-ENaC protein abundance for the uncleaved (85 kDa) band was 
significantly increased and for the cleaved (70 kDa) band significantly decreased in 
AS-/- mice. ROMK protein abundance (glycosylated and nonglycosylated) was not 
different between the genotypes. These results indicate decreased ENaC cleavage 
in AS-/- after 5% K+ loading. 
 
Figure 23. Expression of ENaC and ROMK in mouse kidneys during 5% K+ loading. (A) 
Immunoblots for α-, β- and γ-ENaC subunits and ROMK in total membrane fractions from 
mouse kidneys. All membranes were reprobed for β-actin and all data were normalized 
against β-actin. Bar graphs summarizing data from immunoblotting. n = 5 mice per group. 
Values are mean ± SEM. * p ≤ 0.05, *** p ≤ 0.001.  
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Figure 24. Subcellular distribution of ENaC and ROMK in mouse kidneys during 5% K+ 
loading. Immunolocalization of β-ENaC and ROMK in mouse kidney sections. β-ENaC 
staining is mostly localized to apical membranes in wild type (+/+) mice whereas in 
aldosterone synthase-deficient mice (-/-) staining is mostly cytoplasmic. ROMK staining is 
localized to apical membranes in both +/+ and  -/- mice. 
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4.1.3 Functional ENaC and apical localization of ENaC in the late DCT in AS-/- 
mice on 2% K+ diet 
To determine in vivo the functional activity of ENaC, mice were treated with 
amiloride, a specific blocker of ENaC. Urinary Na+ excretion was significantly higher 
in the amiloride-treated group compared to vehicle-treated group in AS+/+ mice as 
well as in AS-/- mice indicating active ENaC channels in both AS+/+ and AS-/- mice 
(figure 25C). Furthermore, immunohistochemistry showed an apical localization of β- 
and γ-ENaC in the late DCT to but a mostly cytoplasmic localization of the channel in 
the CNT and CCD in AS-/- mice (figure 25A). These results indicate that in AS-/- mice, 
there may be functionally active ENaC channels in the kidney and they are mainly 
located in the late DCT. To further confirm the functional activity of ENaC in the late 
DCT, ex vivo patch clamping experiments were performed for ENaC (figure 25B) on 
isolated, split-open DCT2, CNT and CCD segments from AS+/+ and AS-/- mice kept 
on 2% K+ diet. Consistent with the results from immunohistochemistry, similar whole-
cell-amiloride-sensitive-currents were observed in the early ASDN segments of AS+/+ 
and AS-/- mice.  
4.1.4 Impaired activation of colonic Na+ and K+ channels in AS-/- during 2% K+ 
loading 
We also examined if similar aldosterone-independent functional ENaC channels 
were present in distal colon. Barium-sensitive K+ channel currents and amiloride-
sensitive Na+ channel currents (figure 26) were significantly increased in AS+/+  mice 
after 4 days of 2 % K+-loading, but absent in AS-/- mice. This indicates that 
aldosterone, unlike in the kidney, is essential for the regulation for ENaC in response 
to K+-loading in the distal colon. 
 
 
 
65 
 
 
Figure 25. Functional activity and subcellular distribution of ENaC in kidney colon 
during 2% K+ loading. (A) Immunolocalization of the ENaC β- and γ-subunits in the late 
distal convoluted tubule (DCT) and connecting tubule (CNT) in kidney sections from  
aldosterone synthase-deficient (AS-/-) mice. (B) Amiloride sensitive whole cell Na+ channel 
currents in the early aldosterone sensitive distal nephron (ASDN) from AS+/+ and AS-/- mice 
on 2% K+ diet, n = 7-9 mice per group. (C) Urinary Na+ excretion after 4 h of vehicle or 
amiloride injection. N = 8-11. Values are mean ± SEM. *** p ≤ 0.001.  
 
 
 
 
 
 
Figure 26. Functional activity of ENaC and BK channel in distal colon during  2% K+ 
loading. Ussing chamber recordings of barium sensitive K+ channel and amiloride sensitive 
Na+ channel currents in the distal colon. N = 5-6 mice per group. Values are mean ± SEM. * 
p ≤ 0.05. 
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4.1.5   Role of angiotensin II in AS-/- mice 
Mice were treated with losartan, an antagonist for the angiotensin type 1 receptor 
(AT1R) to get insights in the role of angiotensin II for the rather compensated 
phenotype of AS-/- mice, which is evident even on a high K+ (2% K+) diet. Food intake 
was significantly decreased in losartan treated AS-/- mice compared to vehicle 
treated AS-/- animals (3.1 ± 0.4 g vs. 5.5 ± 0.2 g, P = 0.0015) indicating food 
avoidance after losartan treatment, whereas no difference in food intake was 
observed in losartan vs. vehicle treated AS+/+ mice (5.5 ± 0.6 g vs. 5.3 ± 0.2 g, P = 
0.8). No significant difference was seen in water intake in losartan vs. vehicle treated 
AS-/- mice (2.6 ± 0.3 ml vs. 2.2 ± 0.2 ml, P= 0.4) as well as in AS+/+ mice (1.4 ± 0.1 ml 
vs. 1.0 ± 0.1 ml, P = 0.06). Urinary Na+ excretion was significantly decreased in 
losartan-treated AS-/- mice compared to vehicle-treated animals. K+ excretion in urine 
was also significantly decreased in the losartan-treated AS-/- mice. In contrast, no 
significant difference in urinary Na+ and K+ excretion was observed in losartan 
treated vs. vehicle treated AS+/+ mice (figure 27A). Hyponatremia was seen in the 
losartan treated AS-/- mice as shown by significantly decreased plasma Na+ 
concentration compared to vehicle treated mice. Interestingly, losartan treated AS-/- 
mice were hyperkalemic as shown by significantly higher plasma K+ concentrations 
compared to vehicle treatment (figure 27B). Immunohistochemistry showed apical 
localization of βENaC in vehicle-treated mice but mostly cytoplasmic after losartan 
treatment in kidney sections from AS-/- mice (figure 27C). 
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Figure 27. Effect of angiotensin type 1 receptor (AT1R) inhibition by losartan during        
2% K+ loading on Na+ and K+ concentrations in blood and urine. (A) Urinary Na+ and K+ 
excretion in mice after 13 h of vehicle or losartan treatment. (B) Blood Na+ and K+ 
concentrations in mice after 13 h of vehicle or losartan treatment. n = 5, losartan group;            
n = 4, vehicle group. (C) Immunolocalization of the β-ENaC subunit in the early ASDN from 
vehicle and losartan treated mice. +/+, wild type mice;   -/-, aldosterone synthase-deficient 
mice. Values are mean ± SEM. * p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001. 
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4.1.6   Decreased sodium chloride co-transporter (NCC) protein expression 
and activity in AS-/- mice on 2% K+ diet 
Next, we tested the expression and functional activity of NCC as the Na+ 
reabsorption by NCC along the DCT may affect or modulate the Na+ and K+ transport 
systems in further downstream nephron portions. The results from qPCR showed no 
significant difference in NCC mRNA expression between the genotypes (figure 28A). 
In contrast, immunoblots, for total NCC and for phospho-specific forms of NCC, 
namely phosphothreonine 53 (pT53), phosphothreonine 58 (pT58) and 
phosphoserine 89 (pS89), showed significant decreases in NCC protein abundance 
and phosphorylation in AS-/- mice compared to AS+/+ (figure 28B). 
To assess the in-vivo functional relevance of the reduced NCC abundance 
and phosphorylation, mice were injected either with DMSO as vehicle or with the 
diuretic hydrochlorothiazide to inhibit NCC. Urine was collected and analyzed for ion 
excretion. Urinary Na+ excretion was significantly higher in hydrochlorothiazide 
treated vs. DMSO treated AS+/+ mice as well as in AS-/- mice, but in line with the 
immunoblot results, urinary Na+ excretion in hydrochlorothiazide-treated AS-/- mice 
was significantly lower than in hydrochlorothiazide-treated AS+/+ mice (figure 28C).  
4.1.7   Similar deoxycoticosterone levels in AS-/- mice on control and 2% K+ diet 
To check for the possibility that increased deoxycorticosterone levels in AS-/- mice 
might activate the MR, 11-deoxycorticosterone levels were measured in urine 
samples (figure 29). No significant difference in the concentration of 11-
deoxycorticosterone levels was observed on control diet between AS+/+ and AS-/- 
mice. During 2% K+ diet 11-deoxycorticosterone levels were significantly decreased 
in AS+/+ mice compared to AS-/- mice. The 11-deoxycorticosterone levels were not 
significantly different in AS-/- mice on control and 2% K+ diet. 
4.1.8   AS-/- mice can concentrate urine similar to AS+/+ mice 
AS-/- mice excrete more urine than AS+/+ mice. Therefore we checked for protein 
abundance and subcellular localization of AQP2 in kidneys. In AS+/+ mice, AQP2 is 
localized to the apical membrane whereas in AS-/- AQP2 is mostly cytoplasmic 
(figure 30A). Protein abundance for AQP2 was increased in AS-/- mice as seen in 
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immunoblots (figure 30B). Urine osmolarity was significantly increased in AS+/+ as 
well as in AS-/- after DDAVP treatment (figure 30C). The plasma Na+ levels were 
significantly decreased in AS+/+ and AS-/- mice after DDAVP treatment. In contrast, 
no significant change in levels of plasma K+ was seen in AS+/+ and AS-/- mice after 
DDAVP treatment.   
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Figure 28. Expression and in vivo functional activity of the sodium chloride co-
transporter (NCC) in mouse kidneys during 2% K+ loading. (A) Real-time RT-PCR was 
used to assess NCC mRNA levels in mouse kidneys. n = 7 mice per group. (B) 
Immunoblotting for total NCC and phosphorylated forms of NCC at residues threonine 53 
(pT53 NCC), threonine 58 (pT58 NCC) and serine 89 (pS89 NCC) normalized against β-
actin in total membrane fractions from mouse kidneys. Bar graphs summarizing data from 
immunoblotting. n = 5 mice per group. (C) Urinary Na+ excretion after 4 h of 
dimethylsulfoxide (DMSO, vehicle) or hydrochlorthiazide (HCTZ) treatment. n = 8, DMSO 
+/+ group; n = 9 for +/+ HCTZ, -/- DMSO and HCTZ group. Values are mean ± SEM. * p ≤ 
0.05, *** p ≤ 0.001. 
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Figure 29. Concentration of 11- deoxycoticosterone in urine samples from AS+/+ and 
AS-/- mice. Control diet n = 5 for each group; 2% K+ diet n = 4 for AS+/+ mice and n = 7 for 
AS-/- mice. Values are mean ± SEM. * p ≤ 0.05. 
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Figure 30. Expression and subcellular distribution of aquaporin 2 (AQP2) water 
channel and its response to desmopressin (1-deamino-8-D-arginine vasopressin 
(DDAVP)) treatment on 2% K+ loading. (A) Immunolocalization of AQP2 water channel in 
cortical collecting duct (CCD) and inner medullary collecting duct (IMCD) in kidney sections 
from mice. (B) Immunoblot of AQP2 protein and β-actin as a loading control showing protein 
abundance in total membrane fractions from whole kidneys. (C) Urine was collected before 
and 4 h after DDAVP treatment from mice on 2% K diet and osmolarity was measured. 
Urinary osmolarity is increased in both +/+ and -/- mice after DDAVP treatment. n = 5 mice 
per group (D) Blood Na+ and K+ concentration after 4 h of vehicle or DDAVP treatment. 
Lower blood Na+ concentration in DDAVP treated mice compared to vehicle group and 
unchanged K+ concentration. n = 5 mice per group. Values are mean ± SEM. * p ≤ 0.05, ** p 
≤ 0.01, *** p ≤ 0.001. 
 
Plasma Na
 Veh.  DDAVP Veh. DDAVP
140
145
150
155
160
*
*
+/+ -/-
** *
N
a
 (
m
m
o
l)
Plasma K
 Veh.  DDAVP  Veh.  DDAVP
0
1
2
3
4
5
+/+ -/-
K
 (
m
m
o
l)
Urine osmolarity
Before DDAVP Before DDAVP
0
500
1000
1500
2000
2500
*** ***
+/+ -/-
U
o
s
m
 (
m
O
s
m
)
A B
D
CCD
IMCD
+/+ -/-
35-40 kDa
25 kDa
43 kDa
AQP2
actin
C
+/+ -/-
73 
 
4.2. Role of aldosterone in pregnancy  
4.2.1 Absence of a maternal preeclamptic phenotype in AS-/- mice during 
pregnancy  
To test the hypothesis that aldosterone deficiency during pregnancy may contribute 
to the pathogenesis of pre-eclampsia, we measured SBP and urinary protein 
excretion in AS+/+ and AS-/- dams before and during pregnancy. In order to eliminate 
the genotype of the fetuses as confounding factor, AS+/+ females were mated to AS-/- 
males and AS-/- females to AS+/+ males producing only AS+/- offspring. Before and 
during pregnancy, SBP was significantly higher in AS+/+ than in AS-/- dams (figure 
31A). While blood pressure of AS+/+ remained constant at about 110 mmHg 
throughout pregnancy, SBP in AS-/- dams decreased from about 105 mmHg at day 1 
to about 90 mmHg at day 21. Importantly, there was no difference in urinary protein 
excretion and no increase in AS+/+ and AS-/- mice during pregnancy (figure 31B). 
Thus, AS-/- dams did not become hypertensive and did not develop proteinuria during 
pregnancy.   
4.2.2 Presence of a feto-placental phenotype in AS-/- mice on control diet 
Mean litter size at birth was lowered in AS-/- dams compared to AS+/+ mice (3.0 ± 
0.55 vs. 6.22 ± 0.66, respectively; p<0.005) representing a strong fetal phenotype 
(figure 31C). To examine whether the reduced litter size at birth was due to 
intrauterine death of fetuses, dams were sacrificed on gestational day 18 (E18) and 
the number and weight of fetuses and placentas were measured. The mean litter 
size was again smaller in AS-/- compared to AS+/+ dams (2.67 ± 0.54 vs. 7.13 ± 0.48, 
respectively; p<0.0001) (Figure 26A). The reduction of the number of pups paralleled 
the presence of dark and necrotic placentas in AS-/- mice (figures 32A and 32B). 
Necrotic placentas were mostly observed in series next to each other but sometimes 
also observed interspersed between healthy placentas. Necrotic placentas were not 
seen in any AS+/+ dams on control diet. 
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Figure 31. Systolic blood pressure, proteinuria and litter size on control diet. (A) 
Systolic blood pressure measured during the course of pregnancy from day 0 to day 21 in 
AS+/+ (n = 6-9 animals/time point) and AS-/- (n = 3-9 animals/time point) dams. (B) Urine 
protein concentration normalized to creatinine measured from spot urine during pregnancy in 
AS+/+ (n = 3) and AS-/- dams (n = 6). (C.) Number of pups counted on the day of delivery in 
AS+/+ (n = 9) and AS-/- (n = 9) dams. Values are mean ± SEM. *P < 0.05, **P < 0.005, ***P < 
0.001 vs.  AS+/+. 
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Figure 32. Litter size, litter and placenta weights, and healthy and necrotic 
placentas in AS+/+ and AS-/- dams on day 18 of pregnancy. (A) Number of fetuses 
and necrotic placentas were counted in the uterus from AS+/+ (n = total number of fetuses 
and placentas from 8 females) and AS-/- dams (n = total number of fetuses and placentas 
from 15 females). (B) Photos of fetuses and placentas in the uterus from AS+/+ and AS-/- 
dams and comparison of healthy and necrotic placenta. (C) Mean litter and mean placenta 
weight vs. litter size in AS+/+ (n = 8 litters) and AS-/- dams (n = 12 litters). Values are mean ± 
SEM. **P < 0.005, ***P < 0.001 vs.  AS+/+. 
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When the mean litter and placenta weights were plotted against litter sizes 
(figure 32C), it became evident that the data for the AS-/- mice were not only shifted 
to smaller litter sizes but also to reduced litter and placenta weights. This is most 
evident when litters of the same sizes in AS-/- and in AS+/+ are compared (i.e. litter 
sizes of 5 and 7 pups in figure 32C). In contrast, in very small litters (n = 1-3), 
placental weight appeared to be normal. Histological examination of the placentas 
further confirmed the reduced size of placentas in AS-/- dams, but did also reveal that 
most of the placentas were otherwise healthy with a similar structural organization of 
decidua basalis, junctional zone, and labyrinth as in AS+/+ dams (figure 33A and 33B, 
left and middle section). Only dark placentas from AS-/- dams showed severe 
coagulative necrosis with lymphocyte infiltrations in all three layers of the placenta 
(figure 33A and B, right section). 
4.2.3 High salt diet does not increase intrauterine survival, but improves fetal 
growth in AS-/- mice and lowered systolic blood pressure irrespective of the 
presence of aldosterone 
Based on the assumption that aldosterone deficiency in AS-/- mice might compromise 
placental perfusion, we tested if replacing renal sodium losses by feeding a high salt 
diet (5% NaCl) before and during pregnancy improve the SBP, the weight of 
placentas and of pups, and the litter sizes. AS+/+ and AS-/- females were fed a high 
salt diet starting 12 days before until the end of pregnancy. After 4 days on a high 
salt diet, the SBP rose in both groups of mice, but this increase occurred in parallel 
and hence AS-/-  female mice continued to have lower SBP than AS+/+ female mice 
(figure 34A). During the first days (days 5-7) of pregnancy, the SBP dropped 
significantly in both AS+/+ and AS-/- dams, but the decrease of SBP was much more 
pronounced in AS+/+ mice than in AS-/- mice. Therefore, the BP difference between 
genotypes became very small (days 5-7) and was no longer significant on days 15 to 
17. This is in contrast to the measurements in dams on standard chow, where a 
significant difference in SBP was maintained throughout the entire pregnancy (figure 
31A). In AS-/-, blood pressure lower towards the end of gestation irrespective of the 
salt intake (figure 34B). In AS+/+ mice, the SBP did not drop significantly in pregnancy 
on a normal salt diet. However, if a high salt diet was provided, the blood pressure 
dropped reaching the lowest levels at the end of pregnancy (figure 34C). 
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Figure 33. Histology of placentas. (A) Cross section and H&E stain of a placenta from an 
AS+/+ dam and healthy and necrotic placentas from AS-/- dams. (B) Enlarged section of the 
part of healthy placenta. (C) Enlarged section of the part of the necrotic placenta. Bar = 2000 
µM. DB = decidua basalis, JZ = junctional zone and LZ = labyrinth zone. * indicates 
lymphocyte infiltration and # indicates coagulative necrosis. 
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Of interest, both a low and a high volume state led to a blood pressure 
reduction in pregnancy with the latter being even more consistently throughout 
pregnancy. 
The high Na+ diet did neither increase the mean litter size nor decrease the 
number of necrotic placentas in AS-/- dams (figure 35A). However, the mean weights 
of litters and placentas were no longer different between the genotypes when litters 
of the same sizes were compared (figure 35B). This contrasts with the standard salt 
intake, when both mean litter and placenta weights were smaller in AS-/- than in AS+/+ 
dams (figure 32C). Thus high salt intake does not increase the survival rate of 
fetuses, but appears to improve the intrauterine growth of the surviving pups. 
The beneficial effect of a high salt intake was seen for both genotypes. 
Although the 5% NaCl intake did not increase the mean placental weight, it 
significantly improved the weight of the fetuses in AS+/+ and AS-/- dams (figure 36A 
and 36B). Consistent to these differential effects on fetal and placental growth, 
placental efficiency (ratio of fetal weight over placental weight) was significantly 
increased in both AS+/+ and AS-/- dams on high salt diet compared to control diet 
(figure 36C). Interestingly, placental efficiency was not significantly different between 
AS+/+ and AS-/- dams, neither on control nor on high salt diet (figure 36C). 
4.2.4 Expression of the hypoxia inducible factor HIF1α in the placenta   
Pre-eclampsia is associated with altered expression of key anti- and pro-angiogenic 
factors [109]. We did not detect any differences in the mRNA expression of HIF1α 
(figure 37A), VEGF (figure 37B), and sFlt (figure 37C) between healthy appearing 
placentas from AS+/+ and AS-/- dams kept on either a control or a high salt diet. Since 
HIF1α is mostly regulated at the post-translational level by stabilisation and 
degradation of the protein, we performed immunoblots. HIF1α protein abundance 
was significantly increased in healthy placentas from AS-/- dams on control diet 
(figure 39A). This difference disappeared on high salt diet (figure 33B). HIF1α protein 
was not detected in necrotic placentas (figure 39A). 
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Figure 34. Effect of high salt diet on systolic blood pressure (SBP), litter size, litter 
and placenta weight and necrotic placentas at day 18 of pregnancy (A) SBP was 
measured at different time points (days) before and during pregnancy in AS+/+ (n = 6-8 
animals/time point) and AS-/- (n = 7-10 animals/ time point). (B) In AS-/- mice, no differences 
in blood pressure was observed upon salt loading in pregnancy. SBP compared between 
control and high salt (5% NaCl) diet at different time points just before pregnancy (-4 to -1 
day for control and -10 to -8 for high salt) gestational day 5 to 7 and 15 to 17.  (C) In 
pregnant wild-type mice, salt loading led to a significant drop in blood pressure. SBP 
compared between control and high salt (5% NaCl) diet at different time points just before 
pregnancy (-4 to -1 day for control and -10 to -8 for high salt) gestational day 5 to 7 and 15 to 
17. Values are mean ± SEM. *P < 0.05, **P < 0.005, ***P < 0.001 vs.  AS+/+ (Figure 25A) or 
vs. control diet (Figure 25B, C), ###P < 0.005 vs. high salt (5% NaCl) at -10 to -1 days.  
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Figure 35. Effect of high salt diet on systolic blood pressure, litter size, litter and 
placenta weight and necrotic placentas at day 18 of pregnancy. (A) Number of fetuses 
and necrotic placentas detected in AS+/+ (n = 6) and AS-/- dams (n = 9) at day 18 of 
pregnancy. (B) Mean litter and mean placenta weight vs. litter size in AS+/+ (n = 6) and AS-/- 
dams (n = 9). Values are mean ± SEM. *P < 0.05 vs.  AS+/+. 
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Figure 36. Comparison of litter and placenta weights, and placental efficiency between 
control vs. high salt diet in AS+/+ and AS-/- dams. Mean litter weights (A) and mean 
placenta weights (B) on control diet  vs. high salt diet  in AS+/+ (control diet n = 8 litters, high 
salt diet n = 6 litters) and AS-/- dams (control diet n = 12 litters, high salt diet n = 9 litters). (C) 
Placental efficiency in AS+/+ (control diet n = 8 litters, high salt diet n = 6 litters) and AS-/- 
(control diet n = 13 litters, high salt diet n = 9 litters) dams on control and high salt diet. 
Values are mean ± SEM. *P < 0.05, **P < 0.005, ***P < 0.001 vs. control diet, ## P < 0.005 
vs. AS+/+ on control diet, ***P < 0.001 vs. AS-/- on control diet.  
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Figure 37. Expression of VEGF, sflt and HIF1α in placentas. mRNA expression of HIF1α  
(A) VEGF (B), and sFlt (C) in healthy placentas from AS+/+ (n = 5) and AS-/- (n = 4-5 ) dams 
on control and high salt (5% NaCl) diet. 
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Figure 38. Expression of inflammatory markers MCP-1 and TNFα in placentas. mRNA 
expression of MCP-1 and TNFα was tested by qPCR in healthy placentas from AS+/+ (n = 5), 
and healthy and necrotic placentas from AS-/- (n = 5 each) dams on control (A) and high salt 
(5 % NaCl) (B) diet. Values are mean ± SEM. *P < 0.05 and ***P < 0.001 vs. healthy 
placentas from AS-/-,   **P < 0.005 and ***P < 0.001 vs. AS+/+. 
4.2.5   Expression of pro-inflammatory factors in necrotic placentas 
MCP-1 and TNFα are key pro-inflammatory cytokines involved in inflammatory 
processes. Expression of MCP-1 and TNFα mRNA was significantly increased in 
necrotic placentas from AS-/- dams on control (figure 38A) and high salt diet (figure 
38B) but not in healthy appearing placentas from both genotypes. 
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Figure 39. Protein expression of HIF1α in placentas. The protein abundance of HIF1α 
was examined in placentas from AS+/+ and AS-/- dams on control (A) and high salt (5% NaCl) 
(B) diet. Hypoxic and normoxic control samples are collected from cell culture as positive 
and negative controls, respectively. Bar graph summarize the results from two independent 
blots of n= 6 normalized to β-actin measured on the same membranes. Values are mean ± 
SEM. **P < 0.005 vs. AS+/+. 
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5 DISCUSSION 
5.1 Role of aldosterone in renal potassium excretion 
5.1.1 Adaptation to high potassium diet is possible without aldosterone 
The traditional view of the control of K+ homeostasis assumes that increases in 
plasma K+ concentrations (e.g. in response to a K+ rich meal), directly stimulate 
aldosterone secretion by the adrenal glands. Then, the resulting enhanced plasma 
aldosterone levels stimulate renal K+ secretion until plasma K+ return to normal. This 
classical feed-back model has been challenged by studies of Rabinowitz and others 
[176, 177], who showed that a K+ rich diet may provokes a  kaliuretic response even 
before plasma K+ and plasma aldosterone levels increase [178]. Moreover, they 
showed that aldosterone has very weak kaliuretic activity at normal physiological 
levels, and profoundly affects renal K+ excretion only when elevated to pathological 
levels [176, 179]. Notably, also the well-known circadian variations of urinary K+ 
excretion do not match with the diurnal changes in plasma aldosterone and K+ [176]. 
Based on these observations, Rabinowitz proposed receptors in the gut, portal vein 
or liver responsible for the diet-induced kaliuretic reflex and suggested that the CNS 
and/or kaliuretic factors stimulate renal K+ secretion independent from plasma K+ 
and aldosterone. This would constitute a feed-forward control mechanism for K+ 
homeostasis, which would prime the kidney to excrete K+ to avoid high postprandial 
peaks of plasma K+, with its possible detrimental effects on heart and neuronal 
excitability. In fact recent studies in rat further supported the idea of the existence of 
a gut-dependent feed-forward system that senses K+ intake during a meal and 
rapidly enhances the renal clearance of plasma K+ [180]. In our experiments, we did 
not test for the existence of a gut-dependent feed-forward system that regulates 
renal K+ excretion. However, our data strongly support the idea of an aldosterone-
independent control system. Consistent with this observation, we found increased 
urinary K+ excretion and adaptation in AS-/- mice within a physiologically K+-rich diet 
(2% K+ diet). The increased urinary K+ excretion might be a result of combined 
effects of feed-forward and feedback mechanisms. Decompensation of the system 
occurred at unphysiologically high K+-intake (5% K+ diet). The food aversion in AS-/- 
mice on this unphysiological 5% K+ diet were consistent with previous observations 
in adrenalectomized rats on high K+ diet [181]. In this previous study 
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adrenalectomized rats with basal or 10x times higher aldosterone infusion consumed 
all their diet independent of the amount of K+ supplementation. In contrast, 
adrenalectomized rats with little or no aldosterone supplementation and given 
access to the moderately or highly K+ supplemented diet became anorexic. Despite 
the reduced diet intake, the adrenalectomized rats became hyperkalemic and some 
of them eventually died either because of the anorexia or the hyperkalemia  [181]. 
Consistent with these results, we found that AS-/- mice on 5% K+ diet were 
hyperkalemic and lost body weights. The hyperkalemia and food aversion in this 
experiment was likely related to a decreased capacity to secrete K+ secondary due 
to the lack of aldosterone.  
5.1.2 Aldosterone independent regulation of ROMK and ENaC  
Previous studies on adrenalectomized animals indicated that a high K+ diet 
increases renal Na+ and K+ channel activities independent from aldosterone [166, 
167]. However, adrenalectomies in rodents are often incomplete. Moreover, a 
physiologically relevant local renal aldosterone producing system appears to exist, 
which becomes activated by angiotensin II and a low salt intake in adrenalectomized 
rats [169]. Local synthesis of mineralcorticoids was also observed in other tissue 
including the heart  [182]. In AS-/- mice, any aldosterone production in adrenal and 
extra-adrenal tissues is prevented due to the systemic disruption of the aldosterone-
synthase gene. Thus, our experiments now conclusively demonstrate that a high K+ 
intake increases Na+ and K+ channel activities independent from aldosterone, at 
least as long dietary K+ intake is increased to the physiologically upper limit of 2% 
K+. Apparently, the aldosterone precursors corticosterone [9] and 
deoxycorticosterone (this study) are only marginally or not elevated in AS-/- mice 
suggesting that there is no up-regulation of other members of the corticosteroid axis 
that could compensate for the lack of aldosterone.   
In line with previous studies that suggested aldosterone-independent 
activation of Na+ and K+ channels in response to a high K+ diet [166, 167], we show 
now at the molecular level a maintained K+-diet induced regulation of ENaC and 
ROMK in aldosterone-deficient mice. In both AS+/+ and AS-/- mice the 2% K+ diet 
caused an apical translocation of ROMK and a proteolytic activation of ENaC 
subunits. Likewise, AS-/- mice showed the same natriuretic response to amiloride as 
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the AS+/+ mice and showed similar ENaC sodium currents in the early ASDN 
segments as wild type mice. Immunohistochemistry revealed that in mice of both 
genotypes the K+-diet induced activation of ROMK and ENaC predominantly 
occurred in the early ASDN. Given the fact that aldosterone-binding and expression 
of the mineralocorticoid-receptor appear to be homogenous along the entire ASDN 
[28], the axial gradient along the ASDN of the response of ROMK and ENaC to a 
high K+ diet does already suggest that aldosterone-independent factors significantly 
contribute to the regulation of these two channels along the ASDN.  
The axial gradient of ROMK and ENaC regulation is consistent with the idea 
that the early ASDN is the most critical for the maintenance of Na+ and K+ balance. 
In fact, patch clamp studies in on isolated ASDN segments of rats kept on a high K+ 
diet or treated with aldosterone indicated that ENaC activity is several times larger in 
the CNT than in the CCD [183]. DCTs and CNTs of rats, rabbits and mice have 
several fold higher Na+/+K-ATPase activity than the CDs of the respective species 
[184]. Moreover, several regulatory proteins linked to hypertension or K+ excretion 
such as WNK4, WNK1 and tissue kallikrein are localised in the DCT and CNT rather 
than in the CD. Tissue kallikrein, a serine protease, is a kaliuretic factor involved in 
renal K+ excretion after high K+ loads [185]. Earlier studies in collecting duct specific 
α-ENaC knockout mice showed the importance of the early ASDN (late DCT/CNT) 
for the preservation of Na+ and K+ balance [186]. This study indicated the importance 
of early ASDN (late DCT/CNT) in achieving Na+ and K+ balance and demonstrated 
that expression of ENaC in CD is not a prerequisite to maintain Na+ and K+ balance 
[186].  
5.1.3 Angiotensin II dependent potassium excretion 
AS-/- mice have very high levels of angiotensin II. AT1 receptors have been 
demonstrated by immunohistochemical studies in DCTs, CNTs and CDs [187]. We 
hypothesized that in the absence of aldosterone, the high angiotensin II levels might 
be important to ensure renal K+ excretion. In fact, Inhibition of AT1 receptors for 
angiotensin II by losartan led to a decompensation of AS-/- mice on high 2% K+ diet. 
The mice became severely hyperkalemic and showed a clear avoidance for the K+ 
enriched food. The accompanying hyponatremia was unexpected, but might be due 
to a combination of reduced food intake, normal water intake, and decompensated 
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renal Na+ excretion. Our immunohistochemical data suggest that the 
decompensation of the losartan-treated mice was related to a de-activation of ENaC 
which diminished the driving force for renal K+ secretion along the ASDN. The role of 
angiotensin II for ENaC regulation is supported by several previous studies. Long 
term systemic infusion of angiotensin II increases α-ENaC expression in rat kidney 
cortex [188]. Likewise, AT1 receptor knockout mice have a reduced α-ENaC 
expression despite elevated plasma aldosterone levels [189]. Angiotensin II was 
shown to directly stimulate amiloride-sensitive sodium channel activity in isolated late 
distal tubules and initial collecting ducts. The effect could be blocked by the luminal 
administration of the AT1 receptor blockers candesartan or losartan [190, 191]. 
Furthermore, in type 2 diabetes and obesity inappropriate Na+ retention was 
associated with AT1 receptor dependent activation of ENaC channels [192]. In 
contrast to ENaC, ROMK and SK channel activity was proposed to be inhibited by 
angiotensin II. During dietary K+ restriction, inhibition of AT1 receptors by losartan 
augments apical K+ channel activity likely by interfering with Src family protein 
tyrosine kinase (PTK) and mitogen activated protein kinase (MAPK) dependent 
inhibition of ROMK and BK activity, respectively. However, this effect was only 
evident during dietary K+ restriction. No inhibitory effect of angiotensin II on ROMK or 
BK channel was observed during normal K+ diet [193, 194]. Consistently, in our 
experiments on mice on standard and high K+ diet, we did not find any evidence for 
an inhibitory effect of angiotensin II on ROMK. In fact, the AS-/- mice, which are 
known to have exceedingly high angiotensin II levels [9], showed a rather prominent 
apical ROMK localization that appeared to be even more pronounced than the one 
seen in wild type mice.    
Interestingly, losartan caused hyperkalemia and K+-food avoidance only in   
AS-/-, but not in AS+/+ mice suggesting that  AT1 inhibition is per se not sufficient to 
significantly impair renal K+ handling and hence K+ homeostasis. Only when both 
aldosterone and angiotensin II actions are lacking mice appear to decompensate. 
Consistently,  meta-analysis of clinical studies on patients with hypertension, heart 
failure  and chronic kidney disease (CKD) demonstrated that the incidence of 
hyperkalemia is  below 2% when only one component of the renin-angiotensin-
aldosterone system (RAAS) is inhibited, but increases to about 5-10% (depending on 
the underlying disease) when two components of the RAAS are inhibited. In patients 
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with hypertension, the combination of an aldosterone receptor antagonist with an 
angiotensin II receptor blocker was shown to increase serum K+ level to significantly 
higher values than those seen in patients with a AT1 receptor blocker mono-therapy 
[195]. 
5.1.4 Polyuria-dependent potassium excretion?  
As previously reported [170], AS-/- mice are polyuric. This polyuria is seen already on 
standard diet and becomes even more prominent on a high K+ diet. Because the 
activity of renal potassium channels such as maxi K/BK channels is flow-dependent, 
we speculated that the enhanced diuresis may contribute to the maintained renal K+ 
secretion in AS-/- mice. However, lowering diuresis by injection of the synthetic 
vasopressin analogue DDAVP did not lower urinary K+ excretion and did not 
increase plasma K+ compared to wild type mice. Although we cannot exclude that 
under these condition a vasopressin-dependent activation of K+ channels [196] 
compensated for the lowered flow-dependent K+-channel activation, the data indicate 
that a high urinary flow rate is at least not critical for K+-homeostasis in AS-/- mice. 
Moreover, we could not detect any difference in the mRNA expression of BK channel 
subunits β1, β2 and β4 between wild type and AS-/- mice suggesting that the 
aldosterone-deficiency did not lead to a compensatory up-regulation, at least at the 
mRNA level, of flow-dependent K+-channels in the kidneys of AS-/- mice.  
The reason for the polyuria in AS-/- is unclear. Theoretically, it could be the 
result of an increased water intake due to enhanced thirst or due to renal water loss 
due to an impaired urinary concentration mechanism caused by an insufficient 
secretion of vasopressin from the pituitary (central diabetes insipidus) or caused by 
an insufficient action of vasopressin on the kidney (renal diabetes insipidus). The  
AS-/- deficient mice have exceedingly high angiotensin II levels and angiotensin II is 
known to stimulate thirst [197]. However, previous data from Olivier Smithies group 
showed that AS-/- mice, which were restricted to the same water intake as AS+/+ 
mice, still have a significantly lower urine osmolarity than wild type mice. This 
suggests a renal concentration defect rather than an angiotensin II-induced 
polydipsia as the cause for the observed polyuria [170]. Because it is technically very 
challenging, we did not measure vasopressin levels in our mice, but the previous 
studies from Olivier Smithies reported similar vasopressin levels in wild type and in 
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AS-/- mice suggesting that more likely a renal defect is responsible for the observed 
polyuria. In fact, there is ample evidence that aldosterone increases vasopressin 
mediated water transport in the renal collecting system [198, 199] either by direct 
effects on renal water channels such as AQP3 [200] or by increasing ENaC activity 
which may osmotically drive renal water reabsorption [201]. Consistent with a renal 
water transport defect, our immunofluorescent studies revealed a slightly reduced 
apical localization of the water channel AQP2 in the medullary collecting ducts of  
AS-/- mice, though the total abundance of AQP2 protein (our study) and mRNA [170]  
was found to be increased in AS-/- mice. Despite of the apparent mild trafficking 
defect for AQP2, AS-/- mice are still responsive to vasopressin. In previous studies 
with mice on standard diet as well as in our study on mice on 2% K+ diet, the V2 
receptor-specific agonist DDAVP increased similar urine osmolarity in both  AS+/+ 
and AS-/- mice.  
5.1.5 Aldosterone-independent down regulation of NCC contributes to K+ 
secretion 
Previous studies showed that the thiazide-sensitive Na-Cl co-transporter is an 
aldosterone-induced protein [202]. Consistent with these results, we found a reduced 
total NCC and phospho-NCC abundance. NCC mRNA expression and the fractional 
volume of the DCT was similar for mice of both genotypes indicating that the NCC 
down-regulation occurs at the posttranscriptional level and is independent from a 
major epithelial remodelling of the distal nephron. Consistent with the reduced NCC 
phosphorylation, which is thought to be indicative for a reduced NCC activity [203], 
the AS-/- showed a reduced thiazide-sensitive natriuresis when compared to AS+/+ 
mice. On a high K+ diet, NCC expression and phosphorylation decreased in mice of 
both genotypes indicating that NCC-downregulation might be part of the homeostatic 
response of the kidney to dietary K+ loading and that this effect is aldosterone-
independent.  
Although the underlying mechanism for the K+-induced downregulation of 
NCC is unclear, the functional consequences are likely important for the 
maintenance of K+ balance. The decreased NCC activity augments Na+ delivery to 
the early ASDN where then the increased luminal Na+ concentration increases the 
driving force for Na+ reabsorption via ENaC which eventually fosters K+ secretion via 
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ROMK. A strong relationship between high Na+ delivery to the distal tubule and 
increased K+ excretion is well established [22, 204]. Also patients with Gitelman’s 
syndrome due to loss-of-function mutations in NCC tend to have an increased renal 
K+ excretion leading to hypokalemia [205]. Conversely, patients with 
pseudohypoaldosteronism type II, having an enhanced NCC activity due to 
mutations in WNK kinases, develop hyperkalemia [206]. In these genetic diseases 
not only NCC activity, but also plasma aldosterone levels are changed and it is likely 
that both factors contribute to the altered renal K+ handling. In the AS-/- mice, plasma 
aldosterone levels are constantly set to zero and it appears that K+ homeostasis in 
these mice is largely achieved by adapting the Na+ delivery to the early ASDN in 
which ENaC is activated via angiotensin II.    
5.1.6 Potassium induced activation of Na+ and K+ channels in colon is 
aldosterone dependent 
The distal colon contributes to K+ excretion and thus to K+ homeostasis. The distal 
colon is an aldosterone-sensitive segment and aldosterone is responsible for 
electrogenic Na+ reabsorption through ENaC channels in the distal colon [207]. Also, 
aldosterone is well known to induce K+ secretion through BK channel in the distal 
colon. Previous studies revealed increased mRNA expressions of BK and ENaC 
channels in mouse distal colon on high K+ diet [97, 105]. Consistently, we also 
demonstrated K+ induced activation of ENaC and BK channels in AS+/+ mice but not 
in AS-/- mice indicating the necessity of aldosterone in the distal colon for stimulating 
Na+ absorption and K+ secretion. Loss of distal colon K+ secretion activity in AS-/- 
mice was compensated at least partially by increased K+ secretion in the kidney. 
However, unlike Na+ dependent K+ secretion in the kidney, it is not clear if K+ 
secretion in the distal colon is a Na+ dependent process. One recent study 
demonstrated that BK channels are primarily expressed in crypts and γ-ENaC mainly 
expressed in surface cells of the distal colon. They also showed at the functional 
level that ENaC mediated Na+ reabsorption and BK channels mediated K+ secretion 
are two functionally independent processes [105]. In contrast, two studies with 
radioactive tracer flux measurements in rats with in vivo or in vitro elevated plasma 
aldosterone showed a ~40% reduction of serosal to mucosal tracer fluxes after 
luminal amiloride application indicating reduced K+ secretion [104, 208]. This 
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indicates that a fraction of colonic K+ secretion may also occur in surface epithelial 
cells under elevated aldosterone levels and uses Na+ influx to drive this process or 
that Na+ absorption generates a lumen-negative potential that favours K+-secretion 
by crypt cells. A study using conductance scanning of epithelial surfaces concluded 
that aldosterone induced K+ secretion resides in surface cells and K+ secretion 
induced by adrenaline is present in both crypt as well as in surface epithelial cells 
[208]. It is clear that aldosterone plays an important role in K+ secretion in the distal 
colon, although the exact mechanisms including its Na+ dependency are still not 
clear. 
 
Summary and perspectives 
The final conclusion of this study is summarized in figure 40. In AS+/+ mice, on 
control diet, the major part of the distally delivered Na+ is reabsorbed via NCC in the 
DCT1 and DCT2 and a small remaining portion is reabsorbed via ENaC to maintain 
fluid balance as well as K+ secretion. On the 2% K+ diet, the expression and activity 
of NCC is decreased to increase Na+ delivery to the more distal nephron segments 
to enhance K+ secretion. Therefore AS+/+ mice are able to maintain both fluid volume 
and K+ secretion. Aldosterone plays an important role in ENaC regulation in AS+/+ 
mice. In contrast, in AS-/- mice, on control diet, NCC activity is already decreased 
compared to AS+/+ mice and Na+ is reabsorbed only to some extent by NCC 
transporters in DCT1 and DCT2 but more Na+ is delivered to the distal segments to 
be absorbed by ENaC channels in the early ASDN to maintain both Na+ reabsorption 
and K+ secretion. On the 2% K+ diet, a further decrease in NCC expression and 
activity occurs to further increase Na+ delivery to the early ASDN to stimulate K+ 
secretion in order to excrete the excess K+ load. Angiotensin II might be playing an 
important role for the activation of ENaC channels in the early ASDN in AS-/- mice in 
the absence of aldosterone. On the 5 % K+ diet, residual ENaC activity only in the 
early ASDN in AS-/- mice is not sufficient to maintain the secretion of the very high 
load of K+ and ultimately mice show decompensation.  
In summary, we describe the aldosterone-independent activation of ENaC 
and ROMK in the early ASDN. The permissive effect of angiotensin II was important 
for the residual activity of ENaC to excrete K+. On high K+ diet, the downregulation of 
NCC is an important factor to increase Na+ delivery to the ASDN. We speculate that 
93 
 
the organism of the mice prefers to downregulate Na+ retaining mechanism on the 
expense of a lower blood pressure rather than to risk hyperkalemia with all its 
potentially deleterious effects on excitable tissues. 
 
Figure 40. Model to explain aldosterone dependent and independent regulation of 
renal K+-excretion in AS+/+ and AS-/- mice on control and high K diet.  
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5.2 Role of aldosterone in pregnancy  
Plasma volume expansion in the presence of high aldosterone levels is considered 
crucial for healthy pregnancies, both of which are low in the most severe form of 
hypertensive pregnancies, pre-eclampsia. In order to examine the role of 
aldosterone in the development of pre-eclampsia, we used an aldosterone synthase 
knockout mouse model (AS-/-). AS-/- mice have a compensatory increase of renin and 
angiotensin II to supraphysiological concentrations but no aldosterone [9] allowing to 
independently test the role of aldosterone in pregnancy. Additional effects of these 
high renin and angiotensin II may occur but could not be tested because survival of 
AS-/- mice depends on high angiotensin II levels and pharmacological blockade of 
AT1 receptors is lethal in AS
-/- mice (unpublished observations).  
 New-onset hypertension and proteinuria with feto-placental developmental 
disturbances are considered to be cardinal features of pre-eclampsia [109]. We 
found that AS-/- dams did not develop preeclampsia as suggested by the absence of 
hypertension and proteinuria during pregnancy. A previous study measured SBP by 
telemetry during pregnancy and showed no change in SBP during the first 5 days, 
followed by a drop in SBP from days 6 to12, and again from day 15 to 17 of 
pregnancy [209]. In our hands, using the less sensitive tail cuff method, we found 
reduced SBP in wild type mice during pregnancy in response to salt loading. Though 
contra-intuitive, this observation is in line with some clinical observations during salt 
loading in pregnancy suggesting a beneficial systemic feedback on maternal 
hemodynamics upon optimal placental perfusion [163, 164]. Thus, pre-eclampsia is 
not caused by a lack of aldosterone alone, at least in mice.  
 However, the mouse model revealed a number of other interesting 
observations demonstrating an important role of aldosterone in normal pregnancy. 
AS-/- dams were hypotensive before pregnancy and became even more hypotensive 
during mid to term pregnancy. The resulting feto-placental phenotype of a decreased 
litter size and smaller or necrotic placentas without fetuses at term suggests a 
severe placental hypoperfusion.  The sum of intact fetuses and necrotic placentas in 
AS-/- mice was similar to the average number of fetuses in AS+/+ dams, indicating 
that AS-/- dams were able to conceive normally but had impaired placental 
development and function, predisposing to intrauterine death. The few normal weight 
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placentas and fetuses observed in AS-/- dams carrying small litters would such 
provide a residual blood and nutrient supply to the remaining placentas.  
 Histological examination of healthy placentas from AS-/- dams demonstrated 
normal structural patterns but reduced size. One important reason for lower placental 
weight might be the absence of direct effects of aldosterone on the placenta in AS-/- 
dams. In vitro experiments have  revealed a direct role for aldosterone in the 
modulation of trophoblast  growth and placental size [5] and in vivo studies in ewes 
suggested a role of aldosterone in placental growth [162]. Placental size in rats and 
humans is positively correlated with plasma levels of aldosterone [5]. Thus, 
aldosterone may positively modulate placental growth, similar to its proliferative 
capabilities in organs such as the heart and the kidney [210, 211].  
 Reduced fetal weight in AS-/- dams might thus be due to placental 
insufficiency. In normal human pregnancy, plasma volume expansion is associated 
with increased plasma aldosterone level whereas both were decreased in 
pregnancies with intrauterine growth restriction and pre-eclampsia [146].               
Pre-eclampsia is characterised by extracellular volume expansion but low 
intravascular volume which is caused at least in part by a shift of fluid from the 
intravascular to the interstitial fluid space due to vasoconstriction and leaky 
endothelium [212-214]. Lack of aldosterone in  AS-/- dams might thus critically impair 
plasma volume expansion and thereby cause reduced uterine blood supply similar to 
functional aldosterone deficiency in mice chronically exposed to the 
mineralocorticoid receptor antagonist spironolactone during pregnancy which led to 
reduced fetal umbilical blood flow [5]. Moreover, modelling a reduced uterine blood 
supply by constriction of the uterine artery in rats from gestational day 14 caused 
placental insufficiency resulting in low-birth weight [215].  
 One common cause for the decreased litter size, reduced fetal and placental 
weight, and necrotic and inflammatory placentas in AS-/- dams could be hypoxia. In 
rats, hypoxia during the last 11 days of pregnancy results in smaller sized litters, 
decreased placental and fetal weights, and placental resorption [216]. Low oxygen 
tension affects cytotrophoblast proliferation and invasion and ultimately fetal growth 
[116]. Consistently, the hypoxia-induced factor HIF1, a master regulator in the 
adaption to hypoxia, is essential for mammalian placentation [217]. HIF1α protein 
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abundance was significantly higher in AS-/- mice on control diet, but was reduced to 
control levels on 5% NaCl diet in the normal appearing placentas suggesting hypoxia 
and rescue by high NaCl intake. Consequently, AS-/- necrotic placentas showed 
coagulative necrosis and severe lymphocyte infiltration and elevated levels of pro-
inflammatory cytokines MCP-1 and TNFα. 
 Aldosterone plays a central role in the long-term control of extracellular 
volume by adapting renal and extrarenal reabsorption of sodium to blood pressure 
[17]. Thereby, extracellular NaCl and volume is enlarged, blood pressure and organ 
perfusion increased. AS-/- mice are hypotensive despite highly elevated levels of 
renin and angiotensin II. High salt diet reverses renin and angiotensin II 
abnormalities without increasing blood pressure indicating that the extracellular 
volume status is at least partially normalized [218]. To rescue the possibly reduced 
plasma volume and lower uterine blood flow in AS-/- dams, we treated mice with high 
salt for 12 days before pregnancy until gestational day 18. Both  AS+/+ and AS-/- mice 
responded by increasing SBP suggesting that AS-/- dams also retained salt and fluid 
even though plasma volume was not directly measured.  
 High salt diet had several interesting implications. Next to the blood pressure 
lowering potency in pregnant wild type mice, it partially rescued the fetal phenotype 
with a substantial effect on fetal weight, placental hypoxia, and placental efficiency in 
both AS+/+ and   AS-/- dams. Placental efficiency can be altered experimentally by 
manipulation of uterine blood flow, oxygen availability, and by the intake and 
composition of maternal diet. Increased efficiency is also seen in naturally small 
relative to large placentas in pigs, sheep, goats, rats and mice. Placental efficiency in 
these polytocous species is positively related to litter size [132]. We found that 
smaller placentas in AS+/+ dams on high salt diet and AS-/- dams were associated 
with larger litter size indicating positive correlation between placental efficiency and 
litter size. Decreased placenta weight with larger litter size in AS+/+ dams on high salt 
diet also suggests increased placental efficiency thus supporting an unrestricted fetal 
growth. While small, dark placentas were still observed in AS-/- dams on high salt diet 
similar to control diet it remains amenable a consequence of altered local 
aldosterone availability to support placental development. 
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 Limitations of this model of aldosterone deficiency are the high renin and 
angiotensin II levels which may trigger local dysregulatory events in pre-eclampsia. 
In the absence of aldosterone synthase, deoxycorticosterone, corticosterone and 
some 18-hydroxycorticosterone are still synthesized via 11β-hydroxylase activity. 
Thus, the live-long inhibition of aldosterone synthesis in these animals potentially 
allowing for alternative mineralocorticoid active steroid hormones might have 
supplemented some extrarenal aldosterone effects or even enhanced the inhibition 
of proliferation of trophoblasts via the activation of glucocorticoid receptors.  
Aldosterone availability appears an important prerequisite to support normal 
feto-placental development. AS-/- dams had a feto-placental phenotype with 
decreased litter size, smaller placentas and fetuses, yet no overt pre-eclampsia. In 
the absence of aldosterone, the fetal phenotype might be rescued in part by high salt 
diet. In wild type mice, the high salt diet led to profound blood pressure reduction in 
pregnancy which suggests an important role of plasma volume and placental 
perfusion for maternal well-being. Thus, the absence of aldosterone cannot trigger 
preeclampsia-like symptoms in mice, but might well contribute to the development of 
pre-eclampsia-related intrauterine growth restriction while pre-eclampsia needs to be 
triggered by additional factors. Thus, our study supports the importance of 
aldosterone in placental function in vivo and a possible role for high salt 
supplementation in pregnancies specifically associated with hypoaldosteronism or 
reduced plasma volume expansion to maintain feto-placental integrity. In contrast, in 
pre-eclampsia, the benefits of salt supplementation are still controversial and 
appears have no major impact on outcome as indicated by a recent meta-analysis.  
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6 PERSPECTIVES  
Aldosterone availability appears to be an important prerequisite to support normal 
feto-placental development. This hypothesis is based on the observations that AS-/- 
dams had a feto-placental phenotype with decreased litter size, smaller placentas 
and fetuses, yet no overt pre-eclampsia. In the absence of aldosterone, the fetal 
phenotype might be rescued in part by the restoration of a higher plasma volume by 
the addition of a high salt diet. In wild type mice, the addition of a high salt diet led to 
profound blood pressure reduction in pregnancy which suggests an important role of 
plasma volume and placental perfusion for maternal well-being. Thus, the absence 
of aldosterone cannot trigger pre-eclampsia-like symptoms in mice, but might well 
contribute to the development of pre-eclampsia-related intrauterine growth restriction 
while pre-eclampsia needs to be triggered by additional factors. These data support 
an important role of aldosterone in the placental development as suggested by 
smaller weight and sized placentas, and necrotic and inflammatory placentas in AS-/- 
dams. Thus, our study supports the importance of aldosterone in placental function 
in vivo and a possible role for high salt supplementation in pregnancies specifically 
associated with hypoaldosteronism or reduced plasma volume expansion to maintain 
the feto-placental integrity. Aldosterone deficiency aids to explain reduced placental 
size and decreased fetal weight in pregnancy disorders such as intrauterine growth 
restriction and pre-eclampsia.   
 
 
 
 
 
 
 
 
 
99 
 
REFERENCES 
1. Walter F. Boron, E.L.B., Medical Physiology. 1st ed. 2003, Philadelphia: Saunders. 
2. Takeda, Y., et al., Production of aldosterone in isolated rat blood vessels. Hypertension, 1995. 
25(2): p. 170-3. 
3. Silvestre, J.S., et al., Myocardial production of aldosterone and corticosterone in the rat. 
Physiological regulation. J Biol Chem, 1998. 273(9): p. 4883-91. 
4. Gomez-Sanchez, C.E., et al., Aldosterone biosynthesis in the rat brain. Endocrinology, 1997. 
138(8): p. 3369-73. 
5. Gennari-Moser, C., et al., Regulation of placental growth by aldosterone and cortisol. 
Endocrinology, 2011. 152(1): p. 263-71. 
6. Chapman, A.B., et al., Temporal relationships between hormonal and hemodynamic changes 
in early human pregnancy. Kidney Int, 1998. 54(6): p. 2056-63. 
7. Zennaro, M.C., M. Caprio, and B. Feve, Mineralocorticoid receptors in the metabolic 
syndrome. Trends Endocrinol Metab, 2009. 20(9): p. 444-51. 
8. Boon, W.C., et al., Aldosterone secretion: a molecular perspective. Trends Endocrinol Metab, 
1997. 8(9): p. 346-54. 
9. Lee, G., et al., Homeostatic responses in the adrenal cortex to the absence of aldosterone in 
mice. Endocrinology, 2005. 146(6): p. 2650-6. 
10. Arriza, J.L., et al., Cloning of human mineralocorticoid receptor complementary DNA: 
structural and functional kinship with the glucocorticoid receptor. Science, 1987. 237(4812): 
p. 268-75. 
11. Farman, N. and M.E. Rafestin-Oblin, Multiple aspects of mineralocorticoid selectivity. Am J 
Physiol Renal Physiol, 2001. 280(2): p. F181-92. 
12. Funder, J.W., et al., Mineralocorticoid action: target tissue specificity is enzyme, not receptor, 
mediated. Science, 1988. 242(4878): p. 583-5. 
13. Funder, J.W., Glucocorticoid and mineralocorticoid receptors: biology and clinical relevance. 
Annu Rev Med, 1997. 48: p. 231-40. 
14. Lombes, M., et al., Prerequisite for cardiac aldosterone action. Mineralocorticoid receptor 
and 11 beta-hydroxysteroid dehydrogenase in the human heart. Circulation, 1995. 92(2): p. 
175-82. 
15. Takeda, Y., et al., Expression of 11 beta-hydroxysteroid dehydrogenase mRNA in rat vascular 
smooth muscle cells. Life Sci, 1994. 54(4): p. 281-5. 
16. Robson, A.C., et al., 11 Beta-hydroxysteroid dehydrogenase type 2 in the postnatal and adult 
rat brain. Brain Res Mol Brain Res, 1998. 61(1-2): p. 1-10. 
17. Booth, R.E., J.P. Johnson, and J.D. Stockand, Aldosterone. Adv Physiol Educ, 2002. 26(1-4): p. 
8-20. 
18. Briet, M. and E.L. Schiffrin, Aldosterone: effects on the kidney and cardiovascular system. Nat 
Rev Nephrol, 2010. 6(5): p. 261-73. 
19. Nguyen Dinh Cat, A. and F. Jaisser, Extrarenal effects of aldosterone. Curr Opin Nephrol 
Hypertens, 2012. 21(2): p. 147-56. 
20. Hirasawa, G., et al., 11Beta-hydroxysteroid dehydrogenase type II and mineralocorticoid 
receptor in human placenta. J Clin Endocrinol Metab, 2000. 85(3): p. 1306-9. 
21. Wang, W., Regulation of renal K transport by dietary K intake. Annu Rev Physiol, 2004. 66: p. 
547-69. 
22. Giebisch, G., Renal potassium transport: mechanisms and regulation. Am J Physiol, 1998. 
274(5 Pt 2): p. F817-33. 
23. Giebisch, G.H., A trail of research on potassium. Kidney Int, 2002. 62(5): p. 1498-512. 
24. Wang, W.H. and G. Giebisch, Regulation of potassium (K) handling in the renal collecting 
duct. Pflugers Arch, 2009. 458(1): p. 157-68. 
25. O'Neil, R.G. and R.A. Hayhurst, Functional differentiation of cell types of cortical collecting 
duct. Am J Physiol, 1985. 248(3 Pt 2): p. F449-53. 
100 
 
26. Frindt, G. and L.G. Palmer, Apical potassium channels in the rat connecting tubule. Am J 
Physiol Renal Physiol, 2004. 287(5): p. F1030-7. 
27. Giebisch, G., S.C. Hebert, and W.H. Wang, New aspects of renal potassium transport. 
Pflugers Arch, 2003. 446(3): p. 289-97. 
28. Loffing, J. and C. Korbmacher, Regulated sodium transport in the renal connecting tubule 
(CNT) via the epithelial sodium channel (ENaC). Pflugers Arch, 2009. 458(1): p. 111-35. 
29. Grimm, P.R. and S.C. Sansom, BK channels in the kidney. Curr Opin Nephrol Hypertens, 2007. 
16(5): p. 430-6. 
30. Hebert, S.C., et al., Molecular diversity and regulation of renal potassium channels. Physiol 
Rev, 2005. 85(1): p. 319-71. 
31. Palmer, L.G. and G. Frindt, Na+ and K+ transport by the renal connecting tubule. Curr Opin 
Nephrol Hypertens, 2007. 16(5): p. 477-83. 
32. Meneton, P., J. Loffing, and D.G. Warnock, Sodium and potassium handling by the 
aldosterone-sensitive distal nephron: the pivotal role of the distal and connecting tubule. Am 
J Physiol Renal Physiol, 2004. 287(4): p. F593-601. 
33. Doucet, A. and S. Marsy, Characterization of K-ATPase activity in distal nephron: stimulation 
by potassium depletion. Am J Physiol, 1987. 253(3 Pt 2): p. F418-23. 
34. DuBose, T.D., Jr., J. Gitomer, and J. Codina, H+,K+-ATPase. Curr Opin Nephrol Hypertens, 
1999. 8(5): p. 597-602. 
35. Okusa, M.D., et al., Active potassium absorption by the renal distal tubule. Am J Physiol, 
1992. 262(3 Pt 2): p. F488-93. 
36. Jasti, J., et al., Structure of acid-sensing ion channel 1 at 1.9 A resolution and low pH. Nature, 
2007. 449(7160): p. 316-23. 
37. Bhalla, V. and K.R. Hallows, Mechanisms of ENaC regulation and clinical implications. J Am 
Soc Nephrol, 2008. 19(10): p. 1845-54. 
38. Kellenberger, S. and L. Schild, Epithelial sodium channel/degenerin family of ion channels: a 
variety of functions for a shared structure. Physiol Rev, 2002. 82(3): p. 735-67. 
39. Rossier, B.C. and L. Schild, Epithelial sodium channel: mendelian versus essential 
hypertension. Hypertension, 2008. 52(4): p. 595-600. 
40. Canessa, C.M., et al., Amiloride-sensitive epithelial Na+ channel is made of three homologous 
subunits. Nature, 1994. 367(6462): p. 463-7. 
41. Canessa, C.M., Structural biology: unexpected opening. Nature, 2007. 449(7160): p. 293-4. 
42. Garty, H. and L.G. Palmer, Epithelial sodium channels: function, structure, and regulation. 
Physiol Rev, 1997. 77(2): p. 359-96. 
43. Shigaev, A., et al., Regulation of sgk by aldosterone and its effects on the epithelial Na(+) 
channel. Am J Physiol Renal Physiol, 2000. 278(4): p. F613-9. 
44. Soundararajan, R., et al., A novel role for glucocorticoid-induced leucine zipper protein in 
epithelial sodium channel-mediated sodium transport. J Biol Chem, 2005. 280(48): p. 39970-
81. 
45. Kleyman, T.R., S.A. Ernst, and B. Coupaye-Gerard, Arginine vasopressin and forskolin regulate 
apical cell surface expression of epithelial Na+ channels in A6 cells. Am J Physiol, 1994. 266(3 
Pt 2): p. F506-11. 
46. Snyder, P.M., Liddle's syndrome mutations disrupt cAMP-mediated translocation of the 
epithelial Na(+) channel to the cell surface. J Clin Invest, 2000. 105(1): p. 45-53. 
47. Yamada, T., et al., Frog atrial natriuretic peptide and cGMP activate amiloride-sensitive Na(+) 
channels in urinary bladder cells of Japanese tree frog, Hyla japonica. J Comp Physiol B, 2007. 
177(5): p. 503-8. 
48. Blazer-Yost, B.L., M.A. Esterman, and C.J. Vlahos, Insulin-stimulated trafficking of ENaC in 
renal cells requires PI 3-kinase activity. Am J Physiol Cell Physiol, 2003. 284(6): p. C1645-53. 
49. Gilmore, E.S., M.J. Stutts, and S.L. Milgram, SRC family kinases mediate epithelial Na+ 
channel inhibition by endothelin. J Biol Chem, 2001. 276(45): p. 42610-7. 
101 
 
50. Drummond, H.A., et al., A molecular component of the arterial baroreceptor 
mechanotransducer. Neuron, 1998. 21(6): p. 1435-41. 
51. Drummond, H.A., D. Gebremedhin, and D.R. Harder, Degenerin/epithelial Na+ channel 
proteins: components of a vascular mechanosensor. Hypertension, 2004. 44(5): p. 643-8. 
52. Satlin, L.M., et al., Epithelial Na(+) channels are regulated by flow. Am J Physiol Renal 
Physiol, 2001. 280(6): p. F1010-8. 
53. Carattino, M.D., S. Sheng, and T.R. Kleyman, Mutations in the pore region modify epithelial 
sodium channel gating by shear stress. J Biol Chem, 2005. 280(6): p. 4393-401. 
54. Carattino, M.D., S. Sheng, and T.R. Kleyman, Epithelial Na+ channels are activated by laminar 
shear stress. J Biol Chem, 2004. 279(6): p. 4120-6. 
55. Althaus, M., et al., Mechano-sensitivity of epithelial sodium channels (ENaCs): laminar shear 
stress increases ion channel open probability. FASEB J, 2007. 21(10): p. 2389-99. 
56. Kleyman, T.R., M.M. Myerburg, and R.P. Hughey, Regulation of ENaCs by proteases: An 
increasingly complex story. Kidney Int, 2006. 70(8): p. 1391-2. 
57. Carattino, M.D., et al., The epithelial Na+ channel is inhibited by a peptide derived from 
proteolytic processing of its alpha subunit. J Biol Chem, 2006. 281(27): p. 18901-7. 
58. Sheng, S., et al., Furin cleavage activates the epithelial Na+ channel by relieving Na+ self-
inhibition. Am J Physiol Renal Physiol, 2006. 290(6): p. F1488-96. 
59. Bruns, J.B., et al., Epithelial Na+ channels are fully activated by furin- and prostasin-
dependent release of an inhibitory peptide from the gamma-subunit. J Biol Chem, 2007. 
282(9): p. 6153-60. 
60. Bruns, J.B., et al., Multiple epithelial Na+ channel domains participate in subunit assembly. 
Am J Physiol Renal Physiol, 2003. 285(4): p. F600-9. 
61. Shimkets, R.A., R.P. Lifton, and C.M. Canessa, The activity of the epithelial sodium channel is 
regulated by clathrin-mediated endocytosis. J Biol Chem, 1997. 272(41): p. 25537-41. 
62. Hicke, L. and R. Dunn, Regulation of membrane protein transport by ubiquitin and ubiquitin-
binding proteins. Annu Rev Cell Dev Biol, 2003. 19: p. 141-72. 
63. Staub, O. and D. Rotin, Role of ubiquitylation in cellular membrane transport. Physiol Rev, 
2006. 86(2): p. 669-707. 
64. Liang, X., et al., AS160 modulates aldosterone-stimulated epithelial sodium channel forward 
trafficking. Mol Biol Cell, 2010. 21(12): p. 2024-33. 
65. Diakov, A. and C. Korbmacher, A novel pathway of epithelial sodium channel activation 
involves a serum- and glucocorticoid-inducible kinase consensus motif in the C terminus of 
the channel's alpha-subunit. J Biol Chem, 2004. 279(37): p. 38134-42. 
66. Loffing, J., S.Y. Flores, and O. Staub, Sgk kinases and their role in epithelial transport. Annu 
Rev Physiol, 2006. 68: p. 461-90. 
67. Vandenbosche, R.C. and J.T. Kirchner, Intrauterine growth retardation. Am Fam Physician, 
1998. 58(6): p. 1384-90, 1393-4. 
68. Nichols, C.G. and A.N. Lopatin, Inward rectifier potassium channels. Annu Rev Physiol, 1997. 
59: p. 171-91. 
69. Doyle, D.A., et al., The structure of the potassium channel: molecular basis of K+ conduction 
and selectivity. Science, 1998. 280(5360): p. 69-77. 
70. Minor, D.L., Jr., et al., Transmembrane structure of an inwardly rectifying potassium channel. 
Cell, 1999. 96(6): p. 879-91. 
71. Choe, H., et al., A conserved cytoplasmic region of ROMK modulates pH sensitivity, 
conductance, and gating. Am J Physiol, 1997. 273(4 Pt 2): p. F516-29. 
72. Rapedius, M., et al., Structural and functional analysis of the putative pH sensor in the Kir1.1 
(ROMK) potassium channel. EMBO Rep, 2006. 7(6): p. 611-6. 
73. Wang, W.H., A. Schwab, and G. Giebisch, Regulation of small-conductance K+ channel in 
apical membrane of rat cortical collecting tubule. Am J Physiol, 1990. 259(3 Pt 2): p. F494-
502. 
102 
 
74. Ali, S., et al., The A kinase anchoring protein is required for mediating the effect of protein 
kinase A on ROMK1 channels. Proc Natl Acad Sci U S A, 1998. 95(17): p. 10274-8. 
75. McNicholas, C.M., et al., Regulation of ROMK1 K+ channel activity involves phosphorylation 
processes. Proc Natl Acad Sci U S A, 1994. 91(17): p. 8077-81. 
76. O'Connell, A.D., et al., Phosphorylation-regulated endoplasmic reticulum retention signal in 
the renal outer-medullary K+ channel (ROMK). Proc Natl Acad Sci U S A, 2005. 102(28): p. 
9954-9. 
77. Yoo, D., et al., A phosphorylation-dependent export structure in ROMK (Kir 1.1) channel 
overrides an endoplasmic reticulum localization signal. J Biol Chem, 2005. 280(42): p. 35281-
9. 
78. Liou, H.H., S.S. Zhou, and C.L. Huang, Regulation of ROMK1 channel by protein kinase A via a 
phosphatidylinositol 4,5-bisphosphate-dependent mechanism. Proc Natl Acad Sci U S A, 
1999. 96(10): p. 5820-5. 
79. Huang, C.L., S. Feng, and D.W. Hilgemann, Direct activation of inward rectifier potassium 
channels by PIP2 and its stabilization by Gbetagamma. Nature, 1998. 391(6669): p. 803-6. 
80. Yoo, D., et al., Cell surface expression of the ROMK (Kir 1.1) channel is regulated by the 
aldosterone-induced kinase, SGK-1, and protein kinase A. J Biol Chem, 2003. 278(25): p. 
23066-75. 
81. Loo, T.W. and D.M. Clarke, Location of the rhodamine-binding site in the human multidrug 
resistance P-glycoprotein. J Biol Chem, 2002. 277(46): p. 44332-8. 
82. Zeng, W.Z., et al., Protein kinase C inhibits ROMK1 channel activity via a phosphatidylinositol 
4,5-bisphosphate-dependent mechanism. J Biol Chem, 2003. 278(19): p. 16852-6. 
83. Pluznick, J.L. and S.C. Sansom, BK channels in the kidney: role in K(+) secretion and 
localization of molecular components. Am J Physiol Renal Physiol, 2006. 291(3): p. F517-29. 
84. Schlatter, E., Regulation of ion channels in the cortical collecting duct. Ren Physiol Biochem, 
1993. 16(1-2): p. 21-36. 
85. Schlatter, E., et al., pH dependence of K+ conductances of rat cortical collecting duct principal 
cells. Pflugers Arch, 1994. 428(5-6): p. 631-40. 
86. Taniguchi, J. and M. Imai, Flow-dependent activation of maxi K+ channels in apical 
membrane of rabbit connecting tubule. J Membr Biol, 1998. 164(1): p. 35-45. 
87. Woda, C.B., et al., Flow-dependent K+ secretion in the cortical collecting duct is mediated by 
a maxi-K channel. Am J Physiol Renal Physiol, 2001. 280(5): p. F786-93. 
88. Rieg, T., et al., The role of the BK channel in potassium homeostasis and flow-induced renal 
potassium excretion. Kidney Int, 2007. 72(5): p. 566-73. 
89. Bailey, M.A., et al., Maxi-K channels contribute to urinary potassium excretion in the ROMK-
deficient mouse model of Type II Bartter's syndrome and in adaptation to a high-K diet. 
Kidney Int, 2006. 70(1): p. 51-9. 
90. Gamba, G., The thiazide-sensitive Na+-Cl- cotransporter: molecular biology, functional 
properties, and regulation by WNKs. Am J Physiol Renal Physiol, 2009. 297(4): p. F838-48. 
91. Vallon, V., Regulation of the Na+-Cl- cotransporter by dietary NaCl: a role for WNKs, SPAK, 
OSR1, and aldosterone. Kidney Int, 2008. 74(11): p. 1373-5. 
92. Frindt, G. and L.G. Palmer, Effects of dietary K on cell-surface expression of renal ion channels 
and transporters. Am J Physiol Renal Physiol, 2010. 299(4): p. F890-7. 
93. Ko, B. and R.S. Hoover, Molecular physiology of the thiazide-sensitive sodium-chloride 
cotransporter. Curr Opin Nephrol Hypertens, 2009. 18(5): p. 421-7. 
94. Gordon, R.D. and G.P. Hodsman, The syndrome of hypertension and hyperkalaemia without 
renal failure: long term correction by thiazide diuretic. Scott Med J, 1986. 31(1): p. 43-4. 
95. Gitelman, H.J., J.B. Graham, and L.G. Welt, A new familial disorder characterized by 
hypokalemia and hypomagnesemia. Trans Assoc Am Physicians, 1966. 79: p. 221-35. 
96. Lin, S.H., et al., Phenotype and genotype analysis in Chinese patients with Gitelman's 
syndrome. J Clin Endocrinol Metab, 2005. 90(5): p. 2500-7. 
103 
 
97. Sorensen, M.V., et al., Colonic potassium handling. Pflugers Arch, 2010. 459(5): p. 645-56. 
98. Agarwal, R., R. Afzalpurkar, and J.S. Fordtran, Pathophysiology of potassium absorption and 
secretion by the human intestine. Gastroenterology, 1994. 107(2): p. 548-71. 
99. Foster, E.S., J.P. Hayslett, and H.J. Binder, Mechanism of active potassium absorption and 
secretion in the rat colon. Am J Physiol, 1984. 246(5 Pt 1): p. G611-7. 
100. Foster, E.S., et al., Corticosteroid alteration of active electrolyte transport in rat distal colon. 
Am J Physiol, 1983. 245(5 Pt 1): p. G668-75. 
101. Foster, E.S., et al., Role of aldosterone and dietary potassium in potassium adaptation in the 
distal colon of the rat. Gastroenterology, 1985. 88(1 Pt 1): p. 41-6. 
102. Foster, E.S., et al., Dietary potassium modulates active potassium absorption and secretion in 
rat distal colon. Am J Physiol, 1986. 251(5 Pt 1): p. G619-26. 
103. Halm, D.R. and D.C. Dawson, Potassium transport by turtle colon: active secretion and active 
absorption. Am J Physiol, 1984. 246(3 Pt 1): p. C315-22. 
104. Sweiry, J.H. and H.J. Binder, Characterization of aldosterone-induced potassium secretion in 
rat distal colon. J Clin Invest, 1989. 83(3): p. 844-51. 
105. Sorensen, M.V., et al., The secretory KCa1.1 channel localises to crypts of distal mouse colon: 
functional and molecular evidence. Pflugers Arch, 2011. 462(5): p. 745-52. 
106. Edmonds, C.J., Amiloride sensitivity of the transepithelial electrical potential and of sodium 
and potassium transport in rat distal colon in vivo. J Physiol, 1981. 313: p. 547-59. 
107. Fromm, M. and S.G. Schultz, Potassium transport across rabbit descending colon in vitro: 
evidence for single-file diffusion through a paracellular pathway. J Membr Biol, 1981. 63(1-
2): p. 93-8. 
108. Binder, H.J., sandle, G.I., Electrolyte transport in the mammalian colon. 1994, New York. 
109. Young, B.C., R.J. Levine, and S.A. Karumanchi, Pathogenesis of preeclampsia. Annu Rev 
Pathol, 2010. 5: p. 173-92. 
110. Noris, M., N. Perico, and G. Remuzzi, Mechanisms of disease: Pre-eclampsia. Nat Clin Pract 
Nephrol, 2005. 1(2): p. 98-114; quiz 120. 
111. Briana, D.D. and A. Malamitsi-Puchner, Intrauterine growth restriction and adult disease: the 
role of adipocytokines. Eur J Endocrinol, 2009. 160(3): p. 337-47. 
112. Rosenberg, A., The IUGR newborn. Semin Perinatol, 2008. 32(3): p. 219-24. 
113. Moffett-King, A., Natural killer cells and pregnancy. Nat Rev Immunol, 2002. 2(9): p. 656-63. 
114. Kaufmann, P., S. Black, and B. Huppertz, Endovascular trophoblast invasion: implications for 
the pathogenesis of intrauterine growth retardation and preeclampsia. Biol Reprod, 2003. 
69(1): p. 1-7. 
115. Brosens, I.A., W.B. Robertson, and H.G. Dixon, The role of the spiral arteries in the 
pathogenesis of preeclampsia. Obstet Gynecol Annu, 1972. 1: p. 177-91. 
116. Genbacev, O., et al., Regulation of human placental development by oxygen tension. Science, 
1997. 277(5332): p. 1669-72. 
117. Genbacev, O., et al., Hypoxia alters early gestation human cytotrophoblast 
differentiation/invasion in vitro and models the placental defects that occur in preeclampsia. 
J Clin Invest, 1996. 97(2): p. 540-50. 
118. Ness, R.B. and B.M. Sibai, Shared and disparate components of the pathophysiologies of fetal 
growth restriction and preeclampsia. Am J Obstet Gynecol, 2006. 195(1): p. 40-9. 
119. Caniggia, I., et al., Hypoxia-inducible factor-1 mediates the biological effects of oxygen on 
human trophoblast differentiation through TGFbeta(3). J Clin Invest, 2000. 105(5): p. 577-87. 
120. Caniggia, I., et al., Inhibition of TGF-beta 3 restores the invasive capability of extravillous 
trophoblasts in preeclamptic pregnancies. J Clin Invest, 1999. 103(12): p. 1641-50. 
121. Pijnenborg, R., et al., Immunolocalization of tumour necrosis factor-alpha (TNF-alpha) in the 
placental bed of normotensive and hypertensive human pregnancies. Placenta, 1998. 19(4): 
p. 231-9. 
104 
 
122. Caniggia, I. and J.L. Winter, Adriana and Luisa Castellucci Award lecture 2001. Hypoxia 
inducible factor-1: oxygen regulation of trophoblast differentiation in normal and pre-
eclamptic pregnancies--a review. Placenta, 2002. 23 Suppl A: p. S47-57. 
123. Tazuke, S.I., et al., Hypoxia stimulates insulin-like growth factor binding protein 1 (IGFBP-1) 
gene expression in HepG2 cells: a possible model for IGFBP-1 expression in fetal hypoxia. Proc 
Natl Acad Sci U S A, 1998. 95(17): p. 10188-93. 
124. Kingdom, J.C. and P. Kaufmann, Oxygen and placental vascular development. Adv Exp Med 
Biol, 1999. 474: p. 259-75. 
125. Hodgkinson, C.P., A. Hodari, and F.M. Bumpus, Experimental hypertensive disease of 
pregnancy. Obstet Gynecol, 1967. 30(3): p. 371-80. 
126. Combs, C.A., et al., Experimental preeclampsia produced by chronic constriction of the lower 
aorta: validation with longitudinal blood pressure measurements in conscious rhesus 
monkeys. Am J Obstet Gynecol, 1993. 169(1): p. 215-23. 
127. Villar, J., et al., Preeclampsia, gestational hypertension and intrauterine growth restriction, 
related or independent conditions? Am J Obstet Gynecol, 2006. 194(4): p. 921-31. 
128. Salafia, C. and K. Shiverick, Cigarette smoking and pregnancy II: vascular effects. Placenta, 
1999. 20(4): p. 273-9. 
129. McDonald, A.D., B.G. Armstrong, and M. Sloan, Cigarette, alcohol, and coffee consumption 
and prematurity. Am J Public Health, 1992. 82(1): p. 87-90. 
130. Conde-Agudelo, A., et al., Cigarette smoking during pregnancy and risk of preeclampsia: a 
systematic review. Am J Obstet Gynecol, 1999. 181(4): p. 1026-35. 
131. Barker, D.J. and P.M. Clark, Fetal undernutrition and disease in later life. Rev Reprod, 1997. 
2(2): p. 105-12. 
132. Fowden, A.L., et al., Placental efficiency and adaptation: endocrine regulation. J Physiol, 
2009. 587(Pt 14): p. 3459-72. 
133. Wilson, M.E. and S.P. Ford, Comparative aspects of placental efficiency. Reprod Suppl, 2001. 
58: p. 223-32. 
134. Baur, R., Morphometry of the placental exchange area. Adv Anat Embryol Cell Biol, 1977. 
53(1): p. 3-65. 
135. Mellor, D.J., Nutritional and placental determinants of foetal growth rate in sheep and 
consequences for the newborn lamb. Br Vet J, 1983. 139(4): p. 307-24. 
136. Fowden, A.L., et al., Programming placental nutrient transport capacity. J Physiol, 2006. 
572(Pt 1): p. 5-15. 
137. Fowden, A.L. and A.J. Forhead, Endocrine mechanisms of intrauterine programming. 
Reproduction, 2004. 127(5): p. 515-26. 
138. Jones, H.N., T.L. Powell, and T. Jansson, Regulation of placental nutrient transport--a review. 
Placenta, 2007. 28(8-9): p. 763-74. 
139. Levine, R.J., et al., Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med, 
2004. 350(7): p. 672-83. 
140. Maynard, S.E., et al., Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may 
contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin 
Invest, 2003. 111(5): p. 649-58. 
141. Venkatesha, S., et al., Soluble endoglin contributes to the pathogenesis of preeclampsia. Nat 
Med, 2006. 12(6): p. 642-9. 
142. Shah, D.M., The role of RAS in the pathogenesis of preeclampsia. Curr Hypertens Rep, 2006. 
8(2): p. 144-52. 
143. Shah, D.M., Preeclampsia: new insights. Curr Opin Nephrol Hypertens, 2007. 16(3): p. 213-
20. 
144. Nolten, W.E., et al., Desoxycorticosterone in normal pregnancy. I. Sequential studies of the 
secretory patterns of desoxycorticosterone, aldosterone, and cortisol. Am J Obstet Gynecol, 
1978. 132(4): p. 414-20. 
105 
 
145. Hays, P.M., D.P. Cruikshank, and L.J. Dunn, Plasma volume determination in normal and 
preeclamptic pregnancies. Am J Obstet Gynecol, 1985. 151(7): p. 958-66. 
146. Salas, S.P., et al., Time course of maternal plasma volume and hormonal changes in women 
with preeclampsia or fetal growth restriction. Hypertension, 2006. 47(2): p. 203-8. 
147. Wacker, J., et al., Increased aldosterone-18-glucuronide/tetrahydroaldosterone ratios in 
pregnancy. Endocr Res, 1995. 21(1-2): p. 197-202. 
148. Gallery, E.D., S.N. Hunyor, and A.Z. Gyory, Plasma volume contraction: a significant factor in 
both pregnancy-associated hypertension (pre-eclampsia) and chronic hypertension in 
pregnancy. Q J Med, 1979. 48(192): p. 593-602. 
149. Escher, G. and M. Mohaupt, Role of aldosterone availability in preeclampsia. Mol Aspects 
Med, 2007. 28(2): p. 245-54. 
150. Symonds, E.M., F. Broughton Pipkin, and D.J. Craven, Changes in the renin-angiotensin 
system in primigravidae with hypertensive disease of pregnancy. Br J Obstet Gynaecol, 1975. 
82(8): p. 643-50. 
151. Shojaati, K., et al., Evidence for compromised aldosterone synthase enzyme activity in 
preeclampsia. Kidney Int, 2004. 66(6): p. 2322-8. 
152. Pascoe, L., et al., Mutations in the human CYP11B2 (aldosterone synthase) gene causing 
corticosterone methyloxidase II deficiency. Proc Natl Acad Sci U S A, 1992. 89(11): p. 4996-
5000. 
153. Nicod, J., et al., A biallelic gene polymorphism of CYP11B2 predicts increased aldosterone to 
renin ratio in selected hypertensive patients. J Clin Endocrinol Metab, 2003. 88(6): p. 2495-
500. 
154. Escher, G., et al., High aldosterone-to-renin variants of CYP11B2 and pregnancy outcome. 
Nephrol Dial Transplant, 2009. 
155. Rossant, J. and J.C. Cross, Placental development: lessons from mouse mutants. Nat Rev 
Genet, 2001. 2(7): p. 538-48. 
156. Driver, P.M., et al., Expression of 11 beta-hydroxysteroid dehydrogenase isozymes and 
corticosteroid hormone receptors in primary cultures of human trophoblast and placental 
bed biopsies. Mol Hum Reprod, 2001. 7(4): p. 357-63. 
157. Driver, P.M., et al., Characterization of human trophoblast as a mineralocorticoid target 
tissue. Mol Hum Reprod, 2003. 9(12): p. 793-8. 
158. Schoof, E., et al., Decreased gene expression of 11beta-hydroxysteroid dehydrogenase type 2 
and 15-hydroxyprostaglandin dehydrogenase in human placenta of patients with 
preeclampsia. J Clin Endocrinol Metab, 2001. 86(3): p. 1313-7. 
159. del Monaco, S., et al., [Characterization of the epithelial sodium channel in human pre-
eclampsia syncytiotrophoblast]. Medicina (B Aires), 2006. 66(1): p. 31-5. 
160. Del Monaco, S.M., et al., [Preeclampsia, cellular migration and ion channels]. Medicina (B 
Aires), 2008. 68(5): p. 405-10. 
161. Grifoni, S.C., et al., ENaC proteins contribute to VSMC migration. Am J Physiol Heart Circ 
Physiol, 2006. 291(6): p. H3076-86. 
162. Jensen, E., C.E. Wood, and M. Keller-Wood, Reduction of maternal adrenal steroids results in 
increased VEGF protein without increased eNOS in the ovine placenta. Placenta, 2007. 28(7): 
p. 658-67. 
163. Robinson, M., Salt in pregnancy. Lancet, 1958. 1(7013): p. 178-81. 
164. Farese, S., et al., Blood pressure reduction in pregnancy by sodium chloride. Nephrol Dial 
Transplant, 2006. 21(7): p. 1984-7. 
165. Duley, L., D. Henderson-Smart, and S. Meher, Altered dietary salt for preventing pre-
eclampsia, and its complications. Cochrane Database Syst Rev, 2005(4): p. CD005548. 
166. Muto, S., S. Sansom, and G. Giebisch, Effects of a high potassium diet on electrical properties 
of cortical collecting ducts from adrenalectomized rabbits. J Clin Invest, 1988. 81(2): p. 376-
80. 
106 
 
167. Palmer, L.G., L. Antonian, and G. Frindt, Regulation of apical K and Na channels and Na/K 
pumps in rat cortical collecting tubule by dietary K. J Gen Physiol, 1994. 104(4): p. 693-710. 
168. Stanton, B., et al., Effects of adrenalectomy and chronic adrenal corticosteroid replacement 
on potassium transport in rat kidney. J Clin Invest, 1985. 75(4): p. 1317-26. 
169. Xue, C. and H.M. Siragy, Local renal aldosterone system and its regulation by salt, diabetes, 
and angiotensin II type 1 receptor. Hypertension, 2005. 46(3): p. 584-90. 
170. Makhanova, N., et al., Disturbed homeostasis in sodium-restricted mice heterozygous and 
homozygous for aldosterone synthase gene disruption. Hypertension, 2006. 48(6): p. 1151-9. 
171. Seaton, B. and A. Ali, Simplified manual high performance clinical chemistry methods for 
developing countries. Med Lab Sci, 1984. 41(4): p. 327-36. 
172. Nowik, M., et al., Renal phosphaturia during metabolic acidosis revisited: molecular 
mechanisms for decreased renal phosphate reabsorption. Pflugers Arch, 2008. 457(2): p. 
539-49. 
173. Nowik, M., et al., Genome-wide gene expression profiling reveals renal genes regulated 
during metabolic acidosis. Physiol Genomics, 2008. 32(3): p. 322-34. 
174. Dawson, T.P., et al., Ecto-5'-nucleotidase: localization in rat kidney by light microscopic 
histochemical and immunohistochemical methods. J Histochem Cytochem, 1989. 37(1): p. 
39-47. 
175. Krege, J.H., et al., A noninvasive computerized tail-cuff system for measuring blood pressure 
in mice. Hypertension, 1995. 25(5): p. 1111-5. 
176. Rabinowitz, L., Aldosterone and potassium homeostasis. Kidney Int, 1996. 49(6): p. 1738-42. 
177. Rabinowitz, L., Model of homeostatic regulation of potassium excretion in sheep. Am J 
Physiol, 1988. 254(2 Pt 2): p. R381-8. 
178. Rabinowitz, L., et al., Homeostatic potassium excretion in fed and fasted sheep. Am J Physiol, 
1988. 254(2 Pt 2): p. R357-80. 
179. Rabinowitz, L., R.L. Sarason, and H. Yamauchi, Effects of KCl infusion on potassium excretion 
in sheep. Am J Physiol, 1985. 249(2 Pt 2): p. F263-71. 
180. Lee, F.N., et al., Evidence for gut factor in K+ homeostasis. Am J Physiol Renal Physiol, 2007. 
293(2): p. F541-7. 
181. Rabinowitz, L., T.W. Castonguay, and J.C. Rutledge, Aldosterone reverses potassium-induced 
food aversions in adrenalectomized rats. Physiol Behav, 1988. 42(2): p. 137-40. 
182. Taves, M.D., C.E. Gomez-Sanchez, and K.K. Soma, Extra-adrenal glucocorticoids and 
mineralocorticoids: evidence for local synthesis, regulation, and function. Am J Physiol 
Endocrinol Metab, 2011. 301(1): p. E11-24. 
183. Frindt, G. and L.G. Palmer, Na channels in the rat connecting tubule. Am J Physiol Renal 
Physiol, 2004. 286(4): p. F669-74. 
184. Katz, A.I., A. Doucet, and F. Morel, Na-K-ATPase activity along the rabbit, rat, and mouse 
nephron. Am J Physiol, 1979. 237(2): p. F114-20. 
185. El Moghrabi, S., et al., Tissue kallikrein permits early renal adaptation to potassium load. 
Proc Natl Acad Sci U S A, 2010. 107(30): p. 13526-31. 
186. Rubera, I., et al., Collecting duct-specific gene inactivation of alphaENaC in the mouse kidney 
does not impair sodium and potassium balance. J Clin Invest, 2003. 112(4): p. 554-65. 
187. Harrison-Bernard, L.M., et al., Immunohistochemical localization of ANG II AT1 receptor in 
adult rat kidney using a monoclonal antibody. Am J Physiol, 1997. 273(1 Pt 2): p. F170-7. 
188. Beutler, K.T., et al., Long-term regulation of ENaC expression in kidney by angiotensin II. 
Hypertension, 2003. 41(5): p. 1143-50. 
189. Brooks, H.L., et al., Targeted proteomic profiling of renal Na(+) transporter and channel 
abundances in angiotensin II type 1a receptor knockout mice. Hypertension, 2002. 39(2 Pt 2): 
p. 470-3. 
190. Peti-Peterdi, J., D.G. Warnock, and P.D. Bell, Angiotensin II directly stimulates ENaC activity 
in the cortical collecting duct via AT(1) receptors. J Am Soc Nephrol, 2002. 13(5): p. 1131-5. 
107 
 
191. Wang, T. and G. Giebisch, Effects of angiotensin II on electrolyte transport in the early and 
late distal tubule in rat kidney. Am J Physiol, 1996. 271(1 Pt 2): p. F143-9. 
192. Madala Halagappa, V.K., et al., Chronic candesartan alters expression and activity of NKCC2, 
NCC, and ENaC in the obese Zucker rat. Am J Physiol Renal Physiol, 2008. 294(5): p. F1222-
31. 
193. Wei, Y., et al., Angiotensin II inhibits the ROMK-like small conductance K channel in renal 
cortical collecting duct during dietary potassium restriction. J Biol Chem, 2007. 282(9): p. 
6455-62. 
194. Jin, Y., et al., Inhibition of angiotensin type 1 receptor impairs renal ability of K conservation 
in response to K restriction. Am J Physiol Renal Physiol, 2009. 296(5): p. F1179-84. 
195. Weir, M.R. and M. Rolfe, Potassium homeostasis and renin-angiotensin-aldosterone system 
inhibitors. Clin J Am Soc Nephrol, 2010. 5(3): p. 531-48. 
196. Wang, W.H., Two types of K+ channel in thick ascending limb of rat kidney. Am J Physiol, 
1994. 267(4 Pt 2): p. F599-605. 
197. Fitzsimons, J.T., Angiotensin, thirst, and sodium appetite. Physiol Rev, 1998. 78(3): p. 583-
686. 
198. Schwartz, M.J. and J.P. Kokko, Urinary concentrating defect of adrenal insufficiency. 
Permissive role of adrenal steroids on the hydroosmotic response across the rabbit cortical 
collecting tubule. J Clin Invest, 1980. 66(2): p. 234-42. 
199. Chen, L., S.K. Williams, and J.A. Schafer, Differences in synergistic actions of vasopressin and 
deoxycorticosterone in rat and rabbit CCD. Am J Physiol, 1990. 259(1 Pt 2): p. F147-56. 
200. Kwon, T.H., et al., Regulation of collecting duct AQP3 expression: response to 
mineralocorticoid. Am J Physiol Renal Physiol, 2002. 283(6): p. F1403-21. 
201. Bankir, L., Antidiuretic action of vasopressin: quantitative aspects and interaction between 
V1a and V2 receptor-mediated effects. Cardiovasc Res, 2001. 51(3): p. 372-90. 
202. Kim, G.H., et al., The thiazide-sensitive Na-Cl cotransporter is an aldosterone-induced protein. 
Proc Natl Acad Sci U S A, 1998. 95(24): p. 14552-7. 
203. Richardson, C., et al., Activation of the thiazide-sensitive Na+-Cl- cotransporter by the WNK-
regulated kinases SPAK and OSR1. J Cell Sci, 2008. 121(Pt 5): p. 675-84. 
204. Weinstein, A.M., A mathematical model of rat distal convoluted tubule. I. Cotransporter 
function in early DCT. Am J Physiol Renal Physiol, 2005. 289(4): p. F699-720. 
205. Knoers, N.V. and E.N. Levtchenko, Gitelman syndrome. Orphanet J Rare Dis, 2008. 3: p. 22. 
206. Mayan, H., et al., Pseudohypoaldosteronism type II: marked sensitivity to thiazides, 
hypercalciuria, normomagnesemia, and low bone mineral density. J Clin Endocrinol Metab, 
2002. 87(7): p. 3248-54. 
207. Kunzelmann, K. and M. Mall, Electrolyte transport in the mammalian colon: mechanisms and 
implications for disease. Physiol Rev, 2002. 82(1): p. 245-89. 
208. Grotjohann, I., et al., Localization of cAMP- and aldosterone-induced K+ secretion in rat distal 
colon by conductance scanning. J Physiol, 1998. 507 ( Pt 2): p. 561-70. 
209. Burke, S.D., et al., Spiral arterial remodeling is not essential for normal blood pressure 
regulation in pregnant mice. Hypertension, 2010. 55(3): p. 729-37. 
210. Sohn, H.J., et al., Aldosterone modulates cell proliferation and apoptosis in the neonatal rat 
heart. J Korean Med Sci, 2010. 25(9): p. 1296-304. 
211. Yim, H.E., et al., Aldosterone regulates cellular turnover and mitogen-activated protein 
kinase family expression in the neonatal rat kidney. J Cell Physiol, 2009. 219(3): p. 724-33. 
212. Gallery, E.D. and M.A. Brown, Control of sodium excretion in human pregnancy. Am J Kidney 
Dis, 1987. 9(4): p. 290-5. 
213. Gallery, E.D., Pregnancy-associated hypertension: interrelationships of volume and blood 
pressure changes. Clin Exp Hypertens B, 1982. 1(1): p. 39-47. 
214. Puschett, J.B., The role of excessive volume expansion in the pathogenesis of preeclampsia. 
Med Hypotheses, 2006. 67(5): p. 1125-32. 
108 
 
215. Alexander, B.T., Placental insufficiency leads to development of hypertension in growth-
restricted offspring. Hypertension, 2003. 41(3): p. 457-62. 
216. Huang, S.T., et al., Developmental response to hypoxia. FASEB J, 2004. 18(12): p. 1348-65. 
217. Adelman, D.M., et al., Placental cell fates are regulated in vivo by HIF-mediated hypoxia 
responses. Genes Dev, 2000. 14(24): p. 3191-203. 
218. Makhanova, N., et al., Kidney function in mice lacking aldosterone. Am J Physiol Renal 
Physiol, 2006. 290(1): p. F61-9. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
109 
 
ACKNOWLEDGEMENTS 
I would like to thank: 
- Prof. Carsten Wagner and Prof. Johannes Loffing, my thesis supervisors and 
bosses for giving me the opportunity to work in their groups, their valuable guidance 
and support throughout the years of my thesis; 
- Prof. François Verrey and Prof. Dominique Eladari, members of my thesis 
committee, for valuable suggestions and advice concerning my project; 
- All the people who contributed to the project with their work and expertise- Nicolas 
Picard, Dominique Loffing-Cueni, Mariana Di Chiara, Mads Sorensen, Monique 
Carrel, Nicole Kampik, Carla Bettoni, Marija Mihailova; 
- Our collaborators Prof. Christoph Korbmacher and Viatcheslav Nesterov; Prof. 
Felix Frey and Bernhard Dick for their work and expertise contributing to this project; 
- Prof. Gerhard Rogler, Isabelle Frey-Wagner and Yu Wang for supply of few primers 
and probes 
- All the people working on J-floor in the Institutes of Physiology and Anatomy for 
creating great working atmosphere; 
- My parents (Pandurang and Jyotsna Todkar), Amit and Aparna for their great 
support during all the years of my studies and my PhD; 
- My wife Prajakta for her love and especially for her patience during tough time of 
my PhD; 
- My cousine Kiran and friends Pankaj, Nikhil, Manoj, Dheeraj, Pallavi, Samyuktha 
and Alok for making my life easier in Zurich during PhD; 
Further I would like to thank: 
 
- Zurich Center for Integrative Human Physiology “ZIHP”, for the PhD student 
fellowship. 
 
 
110 
 
CURRICULUM VITAE 
Name    Abhijeet  Pandurang Todkar 
Nationality    Indian 
Marital status   Married 
Date of Birth    20th January 1980 
E-mail      abhijeet.todkar@access.uzh.ch 
Mobile   (041) 789299135 
 
EDUCATION   
 
Since Oct  2007                 PhD fellow, Institute of Physiology and Institute of 
                                              Anatomy),  
                                              University of Zurich,  Switzerland 
   Title of Projects: 1.Aldosterone dependent and   
    independent regulation of potassium homeostasis. 
                                               2. Role of aldosterone in pregnancy 
                                                 
   Project advisors: Prof. Carsten Wagner and Prof.  
   Johannes Loffing   
 
Jan 2006 to Aug 2007        M.Sc. Molecular Biology, University of Skovde, 
                                              Sweden and Eberhard Kares University of 
                                              Tübingen, Germany 
                                              Title of thesis: Transdifferentiation of vascular smooth 
                                              muscle cells. 
                                              Project Advisor: Prof. Robert Feil, (Department of 
                                              Signal Transduction-Transgene Models) 
Jan 2003 to Feb 2005         Master of Veterinary Science   (M.V.Sc.) - Veterinary 
                                              Pathology. 
                                              Bombay Veterinary College (BVC), India. 
 
                                              Title of thesis: Pathology of Streptozotocin (STZ) 
                                              induced hyperglycemia in rat  and effect of herbal 
                                              medicine. 
                                              Project advisor: Prof. P.L. Lonkar 
Sept 2007- Sept 2002          Bachelor of Veterinary science (B.V. Sc.) 
                                              K.N.P. College of veterinary Science, Shirwal Satara 
                                              MAFSU University, Satara 
 
111 
 
                                                
PUBLICATIONS 
 
Papers 
1. Abhijeet Todkar, Marianna Di Chiara, Dominique Loffing-Cueni, Carla Bettoni, 
Markus Mohaupt, Johannes Loffing, Carsten A Wagner. Aldosterone deficiency 
adversely affects pregnancy outcome in mice. Pflügers Arch, in press 
2. Abhijeet Todkar, Nicolas Picard, Dominique Loffing-Cueni, Mads Sorensen, 
Marija Mihailova, Christoph Korbmacher, Natalia Makhanova, Oliver Smithies, 
Carsten Wagner, Johannes Loffing. Aldosterone is dispensable for renal but not for 
colonic regulation of potassium homeostasis. (In preparation).  
 
Abstracts (Poster and Oral Presentations) 
Abhijeet Todkar, Nicolas Picard, Dominique Loffing-Cueni, Marija Mihailova, 
Carsten A. Wagner, Johannes Loffing. Expression of Na+-Cl- cotransporter (NCC) 
and Cl-/anion exchanger pendrin in aldosterone-deficient mice. Poster presented in 
Transporter 2008 meeting, Murten, August 2008, Switzerland. 
Abhijeet Todkar, Jana Kovacikova, Marija Mihailova, Natalia Makhanova, Olivier 
Smithies, Johannes Loffing, Carsten A Wagner. Acidosis in mice lacking aldosterone 
synthase. 5th  symposium of ZHIP (Zurich Center for integrative human Physiology), 
30 August 2009, University   Hospital, Zurich, Switzerland. 
Abhijeet Todkar, Jana Kovacikova, Marija Mihailova, Natalia Makhanova, Olivier 
Smithies, Johannes Loffing, Carsten A Wagner. Acidosis in mice lacking aldosterone 
synthase.ISN Forefronts Symposium on Renal and Extrarenal Control of Acid-
base Homeostasis in Health and Disease, 17 - 20 September 2009, Florence, Italy. 
Abhijeet Todkar, Jana Kovacikova, Marija Mihailova, Natalia Makhanova, Olivier 
Smithies, Johannes Loffing, Carsten A Wagner. Acidosis in mice lacking aldosterone 
synthase.American Society of Nephrology (ASN) Renal Week, 27.10 to 1.11. 2009, 
San Diego, CA, USA. 
Abhijeet Todkar, Jana Kovacikova, Marija Mihailova, Natalia Makhanova, Olivier 
Smithies, Johannes Loffing, Carsten A Wagner. Acidosis in mice lacking aldosterone 
synthase.Joint Meeting of the Scandinavian and German Physiological Societies, 27-
30 September, 2010, Copenhagen, Denmark. 
Abhijeet Todkar, N Picard, D Loffing-Cueni, M Mihailova, N Makhanova3, O 
Smithies, CA Wagner, J Loffing. Aldosterone-dependent and -independent regulation 
of renal potassium excretion. Poster presented in 4th symposium of ZHIP (Zurich 
112 
 
Center for Integrative Human Physiology), 22 August 2008, University Hospital, 
Zurich, Switzerland. 
 A Todkar, M Di Chiara, D Loffing-Cueni, C Bettoni, N Makhanova, O Smithies, J 
Loffing, CA Wagner. Aldosterone deficiency during pregnancy does not lead to 
preeclampsia but results in placenta dysfunction, reduced litter size, and smaller 
pups. Poster presented in 7th International Symposium on Aldosterone and the 
ENaC/Degenerin Family of Ion Channels: Molecular Mechanisms and 
Pathophysiology, September 18-22, 2011. Pacific Grove, CA. 
 Abhijeet Todkar, Nicolas Picard, Mads Sorensen, Natalia Makhanova, 
OliverSmithies, Carsten Wagner, Johannes Loffing. Aldosterone is diepensable for 
renal but not for colonic regulation of potassium homeostasis. Oral presentation in 
7th International Symposium on Aldosterone and the ENaC/Degenerin Family of Ion 
Channels: Molecular Mechanisms and Pathophysiology, September 18-22, 2011. 
Pacific Grove, CA. 
A. Todkar, M. Di Chiara, D. Loffing-Cueni, C. Bettoni, M. G. Mohaupt, J. Loffing, C. 
Wagner. Aldosterone deficiency adversely affects pregnancy outcome in mice. 
Accepted for oral presentation in XVIII International Society for the Study of 
Hypertension in Pregnancy  (ISSHP) World Congress, 9th to 12th July, 2012, Geneva, 
Switzerland. 
 
 
 
 
 
 
 
